Astrocytes	B-cell_type
and	O
glioblastoma	B-cell_type
cells	I-cell_type
express	O
novel	O
octamer-DNA	B-protein
binding	I-protein
proteins	I-protein
distinct	O
from	O
the	O
ubiquitous	B-protein
Oct-1	I-protein
and	I-protein
B	I-protein
cell	I-protein
type	I-protein
Oct-2	I-protein
proteins	I-protein
.	O

The	O
'octamer	B-DNA
'	I-DNA
sequence	I-DNA
,	O
ATGCAAAT	O
or	O
its	O
complement	O
ATTTGCAT	O
,	O
is	O
a	O
key	O
element	O
for	O
the	O
transcriptional	O
regulation	O
of	O
immunoglobulin	B-DNA
genes	I-DNA
in	O
B-lymphocytes	B-cell_type
as	O
well	O
as	O
a	O
number	O
of	O
housekeeping	B-DNA
genes	I-DNA
in	O
all	O
cell	O
types	O
.	O

In	O
lymphocytes	B-cell_type
,	O
the	O
octamer-binding	B-protein
protein	I-protein
Oct-2A	B-protein
and	O
variants	O
thereof	O
are	O
thought	O
to	O
contribute	O
to	O
the	O
B-cell	B-DNA
specific	I-DNA
gene	I-DNA
expression	O
,	O
while	O
the	O
ubiquitous	O
protein	O
Oct-1	O
seems	O
to	O
control	O
general	O
octamer	B-DNA
site	I-DNA
-dependent	O
transcription	O
.	O

Various	O
other	O
genes	O
,	O
for	O
example	O
interleukin-1	B-DNA
and	I-DNA
MHC	I-DNA
class	I-DNA
II	I-DNA
genes	I-DNA
,	O
contain	O
an	O
octamer	B-DNA
sequence	I-DNA
in	O
the	O
promoter	B-DNA
and	O
are	O
expressed	O
in	O
cells	O
of	O
both	O
the	O
immune	O
and	O
nervous	O
systems	O
.	O

This	O
prompted	O
us	O
to	O
analyze	O
the	O
octamer-binding	B-protein
proteins	I-protein
in	O
the	O
latter	O
cells	O
.	O

Using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
at	O
least	O
six	O
novel	O
octamer	B-protein
binding	I-protein
proteins	I-protein
were	O
detected	O
in	O
nuclear	O
extracts	O
of	O
cultured	B-cell_type
mouse	I-cell_type
astrocytes	I-cell_type
.	O

These	O
proteins	O
are	O
differentially	O
expressed	O
in	O
human	B-cell_line
glioblastoma	I-cell_line
and	I-cell_line
neuroblastoma	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

The	O
nervous	B-protein
system-derived	I-protein
(	I-protein
N-Oct	I-protein
)	I-protein
proteins	I-protein
bound	O
to	O
the	O
octamer	B-DNA
DNA	I-DNA
sequence	I-DNA
in	O
a	O
manner	O
which	O
is	O
indistinguishable	O
from	O
the	O
Oct-1	B-protein
and	O
Oct-2A	B-protein
proteins	I-protein
.	O

The	O
relationship	O
of	O
the	O
N-Oct	B-protein
proteins	I-protein
to	O
Oct-1	B-protein
and	O
Oct-2A	B-protein
was	O
analyzed	O
by	O
proteolytic	O
clipping	O
bandshift	O
assays	O
and	O
by	O
their	O
reactivity	O
towards	O
antisera	O
raised	O
against	O
recombinant	O
Oct-1	B-protein
and	O
Oct-2A	B-protein
proteins	O
.	O

On	O
the	O
basis	O
of	O
these	O
assays	O
,	O
all	O
N-Oct-factors	B-protein
were	O
found	O
to	O
be	O
distinct	O
from	O
the	O
ubiquitous	B-protein
Oct-1	I-protein
and	O
the	O
lymphoid-specific	B-protein
Oct-2A	I-protein
proteins	O
.	O

In	O
melanoma	B-cell_type
cells	I-cell_type
that	O
contain	O
the	O
N-Oct-3	B-protein
factor	I-protein
,	O
a	O
transfected	O
lymphocyte-specific	O
promoter	O
was	O
neither	O
activated	O
nor	O
was	O
it	O
repressed	O
upon	O
contransfection	O
with	O
an	O
Oct-2A	B-DNA
expression	I-DNA
vector	I-DNA
.	O

We	O
therefore	O
speculate	O
that	O
N-Oct-3	B-protein
and	O
other	O
N-Oct	B-protein
factors	I-protein
have	O
a	O
specific	O
role	O
in	O
gene	O
expression	O
in	O
cells	O
of	O
the	O
nervous	O
system	O
.	O

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
5495	NULL
Astrocytes	NULL
and	NULL
glioblastoma	NULL
cells	NULL
express	NULL
novel	NULL
octamer-DNA	NULL
binding	NULL
proteins	NULL
distinct	NULL
from	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
and	NULL
B	NULL
cell	NULL
type	NULL
Oct-2	NULL
proteins	NULL
Edgar	NULL
Schreiber*	NULL
,	NULL
Keith	NULL
Harshman	NULL
,	NULL
Iris	NULL
Kemler	NULL
,	NULL
Ursula	NULL
Malipiero	NULL
'	NULL
,	NULL
Walter	NULL
Schaffner	NULL
and	NULL
Adriano	NULL
Fontana	NULL
'	NULL
Institut	NULL
fur	NULL
Molekularbiologie	NULL
II	NULL
der	NULL
Universitat	NULL
Zurich	NULL
,	NULL
HOnggerberg	NULL
,	NULL
8093	NULL
Zurich	NULL
and	NULL
'Abteilung	NULL
fur	NULL
Klinische	NULL
Immunologie	NULL
,	NULL
Departement	NULL
fur	NULL
Innere	NULL
Medizin	NULL
,	NULL
Universitatsspital	NULL
,	NULL
Haldeliweg	NULL
4	NULL
,	NULL
8044	NULL
Zurich	NULL
,	NULL
Switzerland	NULL
Received	NULL
May	NULL
25	NULL
,	NULL
1990	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
August	NULL
15	NULL
,	NULL
1990	NULL
ABSTRACT	NULL
The	NULL
'octamer	NULL
'	NULL
sequence	NULL
,	NULL
ATGCAAAT	NULL
or	NULL
its	NULL
complement	NULL
ATTTGCAT	NULL
,	NULL
is	NULL
a	NULL
key	NULL
element	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
in	NULL
B-lymphocytes	NULL
as	NULL
well	NULL
as	NULL
a	NULL
number	NULL
of	NULL
housekeeping	NULL
genes	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
lymphocytes	NULL
,	NULL
the	NULL
octamer-binding	NULL
protein	NULL
Oct-2A	NULL
and	NULL
variants	NULL
thereof	NULL
are	NULL
thought	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
B-cell	NULL
specific	NULL
gene	NULL
expression	NULL
,	NULL
while	NULL
the	NULL
ubiquitous	NULL
protein	NULL
Oct-1	NULL
seems	NULL
to	NULL
control	NULL
general	NULL
octamer	NULL
site-dependent	NULL
transcription	NULL
.	NULL

Various	NULL
other	NULL
genes	NULL
,	NULL
for	NULL
example	NULL
interleukin-1	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
contain	NULL
an	NULL
octamer	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
and	NULL
are	NULL
expressed	NULL
in	NULL
cells	NULL
of	NULL
both	NULL
the	NULL
immune	NULL
and	NULL
nervous	NULL
systems	NULL
.	NULL

This	NULL
prompted	NULL
us	NULL
to	NULL
analyze	NULL
the	NULL
octamer-binding	NULL
proteins	NULL
in	NULL
the	NULL
latter	NULL
cells	NULL
.	NULL

Using	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
at	NULL
least	NULL
six	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
cultured	NULL
mouse	NULL
astrocytes	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
human	NULL
glioblastoma	NULL
and	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
nervous	NULL
system-derived	NULL
(	NULL
N-Oct	NULL
)	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
octamer	NULL
DNA	NULL
sequence	NULL
in	NULL
a	NULL
manner	NULL
which	NULL
is	NULL
indistinguishable	NULL
from	NULL
the	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
proteins	NULL
.	NULL

The	NULL
relationship	NULL
of	NULL
the	NULL
N-Oct	NULL
proteins	NULL
to	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
was	NULL
analyzed	NULL
by	NULL
proteolytic	NULL
clipping	NULL
bandshift	NULL
assays	NULL
and	NULL
by	NULL
their	NULL
reactivity	NULL
towards	NULL
antisera	NULL
raised	NULL
against	NULL
recombinant	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
proteins	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
assays	NULL
,	NULL
all	NULL
N-Oct-factors	NULL
were	NULL
found	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
and	NULL
the	NULL
lymphoid-specific	NULL
Oct-2A	NULL
proteins	NULL
.	NULL

In	NULL
melanoma	NULL
cells	NULL
that	NULL
contain	NULL
the	NULL
N-Oct-3	NULL
factor	NULL
,	NULL
a	NULL
transfected	NULL
lymphocyte-specific	NULL
promoter	NULL
was	NULL
neither	NULL
activated	NULL
nor	NULL
was	NULL
it	NULL
repressed	NULL
upon	NULL
co-transfection	NULL
with	NULL
an	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
.	NULL

We	NULL
therefore	NULL
speculate	NULL
that	NULL
N-Oct-3	NULL
and	NULL
other	NULL
N-Oct	NULL
factors	NULL
have	NULL
a	NULL
specific	NULL
role	NULL
in	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
selectivity	NULL
of	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
depends	NULL
primarily	NULL
on	NULL
the	NULL
interplay	NULL
of	NULL
transcription	NULL
factors	NULL
present	NULL
in	NULL
a	NULL
given	NULL
cell	NULL
type	NULL
with	NULL
their	NULL
cognate	NULL
recognition	NULL
sequences	NULL
in	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
to	NULL
be	NULL
transcribed	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Maniatis	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
,	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1988a	NULL
)	NULL
.	NULL

The	NULL
particular	NULL
arrangement	NULL
of	NULL
the	NULL
DNA	NULL
modules	NULL
forming	NULL
these	NULL
control	NULL
elements	NULL
allows	NULL
distinct	NULL
regulatory	NULL
factors	NULL
to	NULL
function	NULL
coordinately	NULL
in	NULL
potentiating	NULL
messenger	NULL
RNA	NULL
synthesis	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Ptashne	NULL
1988	NULL
;	NULL
Johnson	NULL
and	NULL
McKnight	NULL
,	NULL
1989	NULL
;	NULL
Mitchell	NULL
and	NULL
Tjian,1989	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
sequence	NULL
motif	NULL
,	NULL
ATGCAAAT	NULL
(	NULL
or	NULL
its	NULL
complement	NULL
ATTTGCAT	NULL
)	NULL
,	NULL
is	NULL
a	NULL
paradigm	NULL
of	NULL
a	NULL
regulatory	NULL
element	NULL
employed	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
both	NULL
ubiquitously	NULL
expressed	NULL
genes	NULL
and	NULL
cell-type	NULL
specific	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
,	NULL
first	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
histone	NULL
H2B	NULL
gene	NULL
(	NULL
Harvey	NULL
et	NULL
al	NULL
.	NULL

1982	NULL
)	NULL
and	NULL
in	NULL
the	NULL
light	NULL
chain	NULL
and	NULL
heavy	NULL
chain	NULL
immunoglobulin	NULL
genes	NULL
(	NULL
Falkner	NULL
and	NULL
Zachau	NULL
,	NULL
1984	NULL
;	NULL
Parslow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
,	NULL
is	NULL
now	NULL
recognized	NULL
,	NULL
with	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
sequence	NULL
variation	NULL
,	NULL
to	NULL
be	NULL
an	NULL
important	NULL
element	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
a	NULL
number	NULL
of	NULL
tissue-specific	NULL
eukaryotic	NULL
genes	NULL
.	NULL

Interestingly	NULL
,	NULL
included	NULL
in	NULL
this	NULL
octamer-responsive	NULL
group	NULL
are	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
B-chain	NULL
enhancer	NULL
(	NULL
Krimpenfort	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
,	NULL
and	NULL
the	NULL
major	NULL
histocompatibility	NULL
antigen	NULL
complex	NULL
(	NULL
MHC	NULL
class	NULL
II	NULL
)	NULL
HLA	NULL
DQB2	NULL
and	NULL
DRa	NULL
(	NULL
Miwa	NULL
and	NULL
Strominger	NULL
1987	NULL
,	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
the	NULL
expression	NULL
of	NULL
which	NULL
is	NULL
cell-type	NULL
specific	NULL
but	NULL
not	NULL
restricted	NULL
to	NULL
B-cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
octamer	NULL
sequence	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
control	NULL
regions	NULL
of	NULL
many	NULL
housekeeping	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
U2	NULL
small	NULL
nuclear	NULL
RNA	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
some	NULL
viruses	NULL
,	NULL
e.g	NULL
.	NULL

SV40	NULL
virus	NULL
,	NULL
herpes	NULL
simplex	NULL
virus	NULL
and	NULL
Adenovirus	NULL
(	NULL
reviewed	NULL
in	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
selective	NULL
use	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
element	NULL
in	NULL
promoting	NULL
ubiquitous	NULL
and	NULL
cell	NULL
type-specific	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
accomplished	NULL
by	NULL
the	NULL
selective	NULL
binding	NULL
of	NULL
a	NULL
ubiquitously	NULL
present	NULL
octamer	NULL
binding	NULL
protein	NULL
(	NULL
Oct-1	NULL
)	NULL
or	NULL
cell	NULL
type-specific	NULL
octamer	NULL
binding	NULL
proteins	NULL
(	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
for	NULL
Ref	NULL
.	NULL

see	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1988a	NULL
and	NULL
Schreiber	NULL
et	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
5496	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
presence	NULL
and	NULL
position	NULL
of	NULL
other	NULL
factor	NULL
binding	NULL
sites	NULL
might	NULL
influence	NULL
the	NULL
exhibited	NULL
affinity	NULL
for	NULL
the	NULL
octamer	NULL
binding	NULL
site	NULL
.	NULL

Of	NULL
course	NULL
,	NULL
relative	NULL
intracellular/	NULL
(	NULL
nuclear	NULL
)	NULL
concentration	NULL
of	NULL
all	NULL
factors	NULL
could	NULL
influence	NULL
octamer-site	NULL
occupancy	NULL
in	NULL
both	NULL
models	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
Oct-1	NULL
and	NULL
the	NULL
lymphoid-specific	NULL
Oct-2A	NULL
proteins	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
Sturm	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
,	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1988b	NULL
;	NULL
Staudt	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
,	NULL
Clerc	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
,	NULL
Scheidereit	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

Ectopic	NULL
overexpression	NULL
of	NULL
the	NULL
Oct-2A	NULL
cDNA	NULL
in	NULL
a	NULL
non-lymphoid	NULL
cell	NULL
led	NULL
to	NULL
transcription	NULL
activation	NULL
of	NULL
a	NULL
lymphoid-specific	NULL
promoter	NULL
construction	NULL
consisting	NULL
of	NULL
an	NULL
octamer	NULL
site	NULL
with	NULL
a	NULL
TATA-box	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

1988b	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
the	NULL
transcriptional	NULL
selectivity	NULL
of	NULL
octamer-containing	NULL
genes	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
cell	NULL
type-specific	NULL
octamer	NULL
binding	NULL
proteins	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
list	NULL
of	NULL
Oct-binding	NULL
proteins	NULL
with	NULL
novel	NULL
tissue	NULL
distributions	NULL
is	NULL
increasingly	NULL
long	NULL
:	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
reported	NULL
on	NULL
a	NULL
testis-specific	NULL
Oct-	NULL
protein	NULL
in	NULL
sea	NULL
urchin	NULL
and	NULL
Cox	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
noted	NULL
a	NULL
novel	NULL
Oct-protein	NULL
in	NULL
extracts	NULL
from	NULL
a	NULL
melanoma	NULL
cell	NULL
line	NULL
;	NULL
a	NULL
developmentally	NULL
regulated	NULL
octamer-binding	NULL
acivity	NULL
in	NULL
F9	NULL
embryocarcinoma	NULL
cells	NULL
was	NULL
described	NULL
(	NULL
Lenardo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
;	NULL
a	NULL
broad	NULL
overview	NULL
of	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
present	NULL
in	NULL
various	NULL
organs	NULL
,	NULL
including	NULL
brain	NULL
and	NULL
embryonic	NULL
tissues	NULL
from	NULL
mouse	NULL
and	NULL
rat	NULL
was	NULL
described	NULL
by	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
;	NULL
three	NULL
Oct-related	NULL
transcripts	NULL
were	NULL
isolated	NULL
from	NULL
rat	NULL
brain	NULL
mRNA	NULL
by	NULL
'PCR-cloning	NULL
'	NULL
and	NULL
shown	NULL
to	NULL
hybridize	NULL
selectively	NULL
to	NULL
different	NULL
regions	NULL
in	NULL
the	NULL
brain	NULL
(	NULL
He	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

An	NULL
indication	NULL
of	NULL
expression	NULL
of	NULL
Oct-2	NULL
mRNA	NULL
in	NULL
certain	NULL
glioma	NULL
cell	NULL
lines	NULL
was	NULL
given	NULL
by	NULL
Staudt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
data	NULL
point	NULL
to	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
large	NULL
but	NULL
related	NULL
family	NULL
of	NULL
octamer-binding	NULL
proteins	NULL
having	NULL
a	NULL
wide	NULL
and	NULL
varied	NULL
tissue	NULL
distribution	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
have	NULL
investigated	NULL
in	NULL
more	NULL
detail	NULL
the	NULL
presence	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
in	NULL
cultured	NULL
mouse	NULL
astrocytes	NULL
as	NULL
well	NULL
as	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
transformed	NULL
cells	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
and	NULL
have	NULL
thoroughly	NULL
analyzed	NULL
their	NULL
relationship	NULL
to	NULL
known	NULL
Oct-proteins	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
the	NULL
astrocytes	NULL
express	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
which	NULL
we	NULL
have	NULL
termed	NULL
N-Oct-2	NULL
«	NULL
and	NULL
B	NULL
,	NULL
N-Oct-3	NULL
,	NULL
N-Oct-4	NULL
and	NULL
N-Oct-5a/5b	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
which	NULL
describe	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
nervous	NULL
system	NULL
derived	NULL
tumor	NULL
cells	NULL
,	NULL
and	NULL
characterize	NULL
the	NULL
biochemical	NULL
features	NULL
of	NULL
these	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
the	NULL
role	NULL
of	NULL
N-Oct-3	NULL
in	NULL
transcription	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
BJA-B	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
(	NULL
Sigma	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
and	NULL
100	NULL
ug	NULL
streptomycin	NULL
.	NULL

The	NULL
nervous	NULL
system	NULL
derived	NULL
tumor	NULL
cell	NULL
lines	NULL
tested	NULL
consisted	NULL
of	NULL
four	NULL
well	NULL
characterized	NULL
human	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
(	NULL
line	NULL
LN-18	NULL
,	NULL
309	NULL
,	NULL
382	NULL
,	NULL
215	NULL
)	NULL
,	NULL
three	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
(	NULL
line	NULL
LAN-1	NULL
,	NULL
SK-N-BE	NULL
and	NULL
SK-N-LE	NULL
)	NULL
,	NULL
and	NULL
one	NULL
melanoma	NULL
line	NULL
(	NULL
Bowes	NULL
)	NULL
and	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
N.	NULL
de	NULL
Tribolet	NULL
,	NULL
Neurosurgical	NULL
Service	NULL
,	NULL
Centre	NULL
Hospitalier	NULL
Universitaire	NULL
Vaudois	NULL
,	NULL
CH-1011	NULL
Lausanne	NULL
,	NULL
Switzerland	NULL
.	NULL

Rat	NULL
C6	NULL
glioma	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
Flow	NULL
Laboratories	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
used	NULL
have	NULL
been	NULL
characterized	NULL
in	NULL
studies	NULL
of	NULL
Biedler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Bissell	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1974	NULL
;	NULL
Schnegg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
;	NULL
Seeger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
;	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
culture	NULL
flasks	NULL
(	NULL
Falcon	NULL
,	NULL
175	NULL
cm	NULL
growth	NULL
area	NULL
)	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
L-glutamin	NULL
(	NULL
0.3	NULL
mg/ml	NULL
)	NULL
.	NULL

Astrocytes	NULL
were	NULL
prepared	NULL
from	NULL
brain	NULL
of	NULL
newborn	NULL
ICR	NULL
+/+	NULL
mice	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
by	NULL
Frei	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
:	NULL
buffers	NULL
A	NULL
and	NULL
C	NULL
contained	NULL
Leupeptin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
as	NULL
an	NULL
additional	NULL
protease	NULL
inhibitor	NULL
at	NULL
4	NULL
ug/	NULL
ml	NULL
buffer	NULL
while	NULL
Buffer	NULL
C	NULL
contained	NULL
20	NULL
%	NULL
Glycerol	NULL
.	NULL

Methylation	NULL
interference	NULL
assay	NULL
This	NULL
assay	NULL
(	NULL
Siebenlist	NULL
and	NULL
Gilbert	NULL
,	NULL
1980	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Kemler	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Preparative	NULL
SDS-PAGE	NULL
and	NULL
renaturation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
These	NULL
procedures	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
:	NULL
a	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
was	NULL
used	NULL
and	NULL
the	NULL
guanidiniumhydrochloride	NULL
denatured	NULL
nuclear	NULL
proteins	NULL
were	NULL
renatured	NULL
by	NULL
adding	NULL
50	NULL
gl	NULL
buffer	NULL
X50	NULL
without	NULL
glycerol	NULL
and	NULL
microdialyzed	NULL
against	NULL
200	NULL
ml	NULL
buffer	NULL
X50	NULL
with	NULL
20	NULL
%	NULL
glycerol	NULL
for	NULL
12	NULL
hrs	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Preparation	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2a	NULL
Antisera	NULL
Recombinant	NULL
Oct-1	NULL
and	NULL
Oct-2a	NULL
were	NULL
used	NULL
as	NULL
antigens	NULL
for	NULL
the	NULL
production	NULL
of	NULL
polyclonal	NULL
antisera	NULL
.	NULL

The	NULL
Oct-2a	NULL
cDNA	NULL
(	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
a	NULL
3	NULL
'	NULL
truncation	NULL
of	NULL
the	NULL
Oct-1	NULL
cDNA	NULL
(	NULL
Sturm	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
under	NULL
the	NULL
control	NULL
of	NULL
an	NULL
IPTG-inducible	NULL
T7	NULL
RNA	NULL
polymerase	NULL
gene	NULL
(	NULL
Studier	NULL
and	NULL
Moffat	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Following	NULL
induction	NULL
,	NULL
the	NULL
insoluble	NULL
recombinant	NULL
protein	NULL
was	NULL
isolated	NULL
in	NULL
the	NULL
inclusion	NULL
body	NULL
fraction	NULL
and	NULL
injected	NULL
(	NULL
150	NULL
ug	NULL
)	NULL
without	NULL
further	NULL
purification	NULL
into	NULL
New	NULL
Zealand	NULL
white	NULL
rabbits	NULL
.	NULL

The	NULL
rabbits	NULL
were	NULL
boosted	NULL
(	NULL
100	NULL
4g	NULL
)	NULL
3	NULL
weeks	NULL
following	NULL
the	NULL
first	NULL
injection	NULL
and	NULL
tested	NULL
for	NULL
an	NULL
immune	NULL
response	NULL
by	NULL
Western	NULL
blotting	NULL
after	NULL
an	NULL
additional	NULL
10	NULL
days	NULL
.	NULL

Both	NULL
sera	NULL
were	NULL
determined	NULL
to	NULL
have	NULL
sufficiently	NULL
high	NULL
titers	NULL
and	NULL
were	NULL
used	NULL
without	NULL
purification	NULL
in	NULL
the	NULL
described	NULL
experiments	NULL
.	NULL

Probes	NULL
for	NULL
bandshift	NULL
analysis	NULL
The	NULL
Ddel-Hinfl	NULL
fragment	NULL
(	NULL
nucleotides	NULL
position	NULL
518-566	NULL
)	NULL
from	NULL
the	NULL
IgH	NULL
enhancer	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Sall-site	NULL
of	NULL
pUC18	NULL
.	NULL

A	NULL
51	NULL
bp	NULL
Sall-fragment	NULL
was	NULL
prepared	NULL
from	NULL
this	NULL
clone	NULL
,	NULL
dephosphorylated	NULL
with	NULL
CLAP	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
and	NULL
5'-end	NULL
labelled	NULL
with	NULL
y-	NULL
>	NULL
%	NULL
p-ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

A	NULL
specific	NULL
activity	NULL
of	NULL
1x	NULL
10®/pmol	NULL
5'-end	NULL
was	NULL
usually	NULL
achieved	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
an	NULL
unlabelled	NULL
fragment	NULL
containing	NULL
4	NULL
copies	NULL
of	NULL
the	NULL
above	NULL
mentioned	NULL
sequence	NULL
was	NULL
used	NULL
(	NULL
octa+	NULL
)	NULL
;	NULL
the	NULL
(	NULL
octa-	NULL
)	NULL
fragment	NULL
contained	NULL
4	NULL
copies	NULL
of	NULL
a	NULL
sequence	NULL
in	NULL
which	NULL
the	NULL
octanucleotide	NULL
motif	NULL
was	NULL
eliminated	NULL
by	NULL
mutation	NULL
from	NULL
ATGCAAAT	NULL
to	NULL
CTGAACAT	NULL
.	NULL

Bandshift	NULL
assay	NULL
and	NULL
proteolytic	NULL
clipping	NULL
The	NULL
procedures	NULL
were	NULL
performed	NULL
exactly	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Transfections	NULL
and	NULL
RNase	NULL
protection	NULL
mapping	NULL
.	NULL

Plasmid	NULL
A	NULL
and	NULL
B	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
identical	NULL
to	NULL
constructs	NULL
©5	NULL
'	NULL
and	NULL
'	NULL
4	NULL
``	NULL
respectively	NULL
,	NULL
used	NULL
by	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988b	NULL
)	NULL
.	NULL

Construct	NULL
C	NULL
in	NULL
this	NULL
study	NULL
is	NULL
identical	NULL
to	NULL
plasmid	NULL
pbG	NULL
(	NULL
Banerji	NULL
et	NULL
al	NULL
.	NULL

1981	NULL
)	NULL
containing	NULL
the	NULL
SV40	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
the	NULL
rabbit	NULL
3-globin	NULL
gene	NULL
.	NULL

COS-7	NULL
and	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
were	NULL
split	NULL
the	NULL
day	NULL
before	NULL
transfection	NULL
;	NULL
at	NULL
the	NULL
time	NULL
of	NULL
transfection	NULL
a	NULL
confluency	NULL
of	NULL
50	NULL
%	NULL
was	NULL
usually	NULL
desired	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
was	NULL
mixed	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
OVEC-REF	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
,	NULL
the	NULL
internal	NULL
standard	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
sonicated	NULL
herring	NULL
sperm	NULL
carrier	NULL
DNA	NULL
and	NULL
applied	NULL
as	NULL
coprecipitates	NULL
to	NULL
the	NULL
cells	NULL
for	NULL
12	NULL
hrs	NULL
;	NULL
3	NULL
ml	NULL
of	NULL
a	NULL
25	NULL
%	NULL
solution	NULL
DMSO	NULL
was	NULL
given	NULL
to	NULL
the	NULL
TBS-washed	NULL
cells	NULL
for	NULL
3	NULL
min	NULL
and	NULL
after	NULL
its	NULL
removal	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
10	NULL
ml	NULL
medium	NULL
for	NULL
30	NULL
more	NULL
hrs	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
extracted	NULL
according	NULL
to	NULL
Gough	NULL
(	NULL
1988	NULL
)	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
with	NULL
a	NULL
B-globin	NULL
SP96	NULL
riboprobe	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988b	NULL
)	NULL
.	NULL

RESULTS	NULL
Nervous	NULL
system-derived	NULL
tumor	NULL
cell	NULL
lines	NULL
contain	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
seven	NULL
neuroblast	NULL
cell	NULL
lines	NULL
:	NULL
four	NULL
human	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
(	NULL
line	NULL
LN-18	NULL
,	NULL
308	NULL
,	NULL
382	NULL
and	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
5497	NULL
215	NULL
)	NULL
and	NULL
three	NULL
human	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
(	NULL
line	NULL
LAN-1	NULL
,	NULL
SK-N-BE	NULL
and	NULL
SK-N-LE	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
one	NULL
human	NULL
melanoma	NULL
cell	NULL
line	NULL
(	NULL
BOWES	NULL
)	NULL
was	NULL
included	NULL
as	NULL
a	NULL
control	NULL
in	NULL
the	NULL
study	NULL
,	NULL
as	NULL
melanocytes	NULL
,	NULL
like	NULL
neuroblasts	NULL
,	NULL
originate	NULL
from	NULL
the	NULL
neuroepithelial	NULL
plate	NULL
.	NULL

Nuclear	NULL
extracts	NULL
containing	NULL
the	NULL
thoroughly	NULL
characterized	NULL
tissue-specific	NULL
octamer	NULL
binding	NULL
proteins	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
were	NULL
prepared	NULL
from	NULL
BJA-B	NULL
lymphocytes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
COS-7	NULL
monkey	NULL
kidney	NULL
epithelial-like	NULL
cells	NULL
and	NULL
from	NULL
mouse	NULL
L-cells	NULL
(	NULL
fibroblasts	NULL
)	NULL
,	NULL
prepared	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
and	NULL
with	NULL
the	NULL
same	NULL
buffers	NULL
as	NULL
the	NULL
other	NULL
samples	NULL
,	NULL
were	NULL
included	NULL
as	NULL
(	NULL
non	NULL
tissue-specific	NULL
)	NULL
controls	NULL
containing	NULL
only	NULL
Oct-1	NULL
protein	NULL
.	NULL

x6	NULL
B	NULL
a	NULL
6	NULL
nervous	NULL
system	NULL
cells	NULL
1	NULL
B-cells	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
Oct1	NULL
_	NULL
-	NULL
QﬁﬂﬁQ	NULL
--	NULL
Oct-1	NULL
A	NULL
$	NULL
1b	NULL
&	NULL
&	NULL
@	NULL
A	NULL
3	NULL
ro	NULL
``	NULL
0	NULL
3	NULL
8	NULL
A	NULL
J	NULL
--	NULL
Oct2B	NULL
s	NULL
(	NULL
Vi/pg	NULL
(	NULL
ego	NULL
Fy	NULL
o	NULL
Aig	NULL
&	NULL
~	NULL
N-Oct	NULL
2	NULL
.	NULL

-	NULL
»	NULL
sh	NULL
With	NULL
Wt	NULL
--	NULL
Oct-2A	NULL
102	NULL
B	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
40	NULL
i1	NULL
B-cells	NULL
__	NULL
nervous	NULL
N-Oct3	NULL
.	NULL

-	NULL
>	NULL
man	NULL
wii	NULL
itt	NULL
@	NULL
R	NULL
SB	NULL
-	NULL
Oct-2C	NULL
1	NULL
I	NULL
system	NULL
N-Oct4	NULL
-	NULL
»	NULL
ws	NULL
,	NULL
cells	NULL
an	NULL
we	NULL
fp	NULL
we	NULL
ae	NULL
qQQQQ	NULL
'	NULL
Oct1	NULL
«	NULL
=	NULL
»	NULL
«	NULL
»	NULL
Oct-1	NULL
NOota	NULL
=-	NULL
mae	NULL
mae	NULL
aay	NULL
am	NULL
eon	NULL
a	NULL
¥	NULL
#	NULL
a	NULL
l	NULL
Oct-	NULL
2B	NULL
@	NULL
@	NULL
w	NULL
€	NULL
wo	NULL
#	NULL
#	NULL
Oct-2A	NULL
@	NULL
@	NULL
awe	NULL
N-Oct2	NULL
we	NULL
as	NULL
sa	NULL
_	NULL
OD	NULL
ts	NULL
an	NULL
Oct-2C	NULL
°	NULL
N-Oct3	NULL
GC	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
V8	NULL
)	NULL
6	NULL
«	NULL
QC	NULL
?	NULL

$	NULL
6	NULL
~~	NULL
V	NULL
?	NULL
)	NULL

$	NULL
:	NULL
b	NULL
.	NULL

Qggﬁﬁ	NULL
®Q§	NULL
Q	NULL
'	NULL
é/ﬁgy	NULL
YP	NULL
@	NULL
Z	NULL
ECEFSYqPO	NULL
Z	NULL
C	NULL
y	NULL
®	NULL
#	NULL
oC	NULL
=F	NULL
Of	NULL
a	NULL
»	NULL
as	NULL
@	NULL
i	NULL
gon	NULL
,	NULL
«	NULL
h	NULL
wane	NULL
sunt	NULL
.~s-	NULL
mutated	NULL
no	NULL
|	NULL
octamer	NULL
octamer	NULL
competitor	NULL
competitor	NULL
competitor	NULL
DNA	NULL
DNA	NULL
DNA	NULL
Figure	NULL
1A	NULL
;	NULL
Autoradiograph	NULL
of	NULL
a	NULL
bandshift	NULL
experiment	NULL
showing	NULL
octamer	NULL
DNA	NULL
binding	NULL
nuclear	NULL
proteins	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
:	NULL
BJA-B	NULL
,	NULL
a	NULL
human	NULL
Burkitt	NULL
lymphoma	NULL
line	NULL
;	NULL
human	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
LN-18	NULL
,	NULL
308	NULL
,	NULL
382	NULL
,	NULL
215	NULL
;	NULL
human	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
LAN-1	NULL
,	NULL
SK-N-BE	NULL
,	NULL
SK-N-LE	NULL
and	NULL
human	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
,	NULL
monkey	NULL
kidney	NULL
fibroblasts	NULL
COS-7	NULL
,	NULL
and	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
L-cells	NULL
)	NULL
.	NULL

The	NULL
origin	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
is	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
schematic	NULL
drawing	NULL
on	NULL
the	NULL
right	NULL
half	NULL
illustrates	NULL
the	NULL
bandshift	NULL
pattern	NULL
and	NULL
nomenclature	NULL
of	NULL
Oct-proteins	NULL
in	NULL
B-lymphocytes	NULL
and	NULL
nervous	NULL
system	NULL
derived	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
radiolabelled	NULL
probe	NULL
was	NULL
the	NULL
51	NULL
bp	NULL
Ddel-Hinfl	NULL
fragment	NULL
from	NULL
the	NULL
mouse	NULL
IgH	NULL
enhancer	NULL
that	NULL
contains	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
ATTTGCAT	NULL
.	NULL

Figure	NULL
1B	NULL
:	NULL
Expression	NULL
of	NULL
octamer	NULL
DNA	NULL
binding	NULL
proteins	NULL
in	NULL
the	NULL
brain	NULL
.	NULL

Extracts	NULL
prepared	NULL
from	NULL
cultured	NULL
murine	NULL
astrocytes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
rat	NULL
C6	NULL
glioma	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
from	NULL
homogenized	NULL
brain	NULL
of	NULL
either	NULL
newborn	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
14	NULL
day	NULL
old	NULL
mice	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
were	NULL
tested	NULL
in	NULL
the	NULL
bandshift	NULL
assay	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
retardation	NULL
pattern	NULL
of	NULL
BJA-B	NULL
lymphocytes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Figure	NULL
1C	NULL
:	NULL
Specificity	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
activities	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
retarded	NULL
complexes	NULL
formed	NULL
by	NULL
Oct-proteins	NULL
of	NULL
the	NULL
various	NULL
cells	NULL
indicated	NULL
is	NULL
demonstrated	NULL
by	NULL
addition	NULL
of	NULL
excess	NULL
unlabelled	NULL
competitor	NULL
DNA	NULL
containing	NULL
either	NULL
the	NULL
intact	NULL
octamer	NULL
motif	NULL
(	NULL
Ddel-Hinfl	NULL
IgH	NULL
enhancer	NULL
fragment	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
)	NULL
or	NULL
a	NULL
mutated	NULL
octamer	NULL
motif	NULL
differing	NULL
in	NULL
three	NULL
out	NULL
of	NULL
eight	NULL
nucleotides	NULL
(	NULL
see	NULL
Material	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

5498	NULL
-	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
A	NULL
radiolabelled	NULL
51	NULL
bp	NULL
Ddel-Hinfl	NULL
octamer-containing	NULL
fragment	NULL
from	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enhancer	NULL
was	NULL
incubated	NULL
with	NULL
these	NULL
extracts	NULL
to	NULL
test	NULL
their	NULL
octamer	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
(	NULL
bandshift	NULL
)	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1A	NULL
,	NULL
extracts	NULL
from	NULL
BJA-B	NULL
lymphocytes	NULL
give	NULL
rise	NULL
to	NULL
three	NULL
prominent	NULL
protein	NULL
DNA	NULL
complexes	NULL
in	NULL
a	NULL
long-run	NULL
bandshift	NULL
experiment	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
slowest	NULL
migrating	NULL
complex	NULL
is	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
Oct-1	NULL
,	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
protein	NULL
.	NULL

The	NULL
second	NULL
most	NULL
retarded	NULL
complex	NULL
is	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
the	NULL
lymphocyte-specific	NULL
protein	NULL
Oct-2B	NULL
followed	NULL
by	NULL
the	NULL
most	NULL
prominent	NULL
Oct-2A	NULL
protein	NULL
complex	NULL
(	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

1988b	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
previously	NULL
described	NULL
Oct-protein	NULL
complexes	NULL
,	NULL
we	NULL
noted	NULL
a	NULL
faint	NULL
and	NULL
faster	NULL
migrating	NULL
band	NULL
at	NULL
the	NULL
lower	NULL
end	NULL
of	NULL
the	NULL
Oct-2A	NULL
complex	NULL
.	NULL

We	NULL
tentatively	NULL
designated	NULL
this	NULL
binding	NULL
activity	NULL
Oct-2C	NULL
.	NULL

By	NULL
analyzing	NULL
tumor	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
the	NULL
nervous	NULL
system	NULL
,	NULL
several	NULL
octamer-DNA	NULL
protein	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
lanes	NULL
2-9	NULL
)	NULL
:	NULL
1	NULL
)	NULL
a	NULL
typical	NULL
Oct-1	NULL
complex	NULL
indistinguishable	NULL
from	NULL
the	NULL
Oct-1	NULL
complex	NULL
in	NULL
BJA-B	NULL
nuclear	NULL
extracts	NULL
,	NULL
2	NULL
)	NULL
a	NULL
doublet	NULL
band	NULL
designated	NULL
N-Oct-2	NULL
(	NULL
N-for	NULL
nervous	NULL
system	NULL
)	NULL
,	NULL
which	NULL
migrates	NULL
close	NULL
to	NULL
,	NULL
but	NULL
slightly	NULL
slower	NULL
than	NULL
the	NULL
Oct-2A	NULL
complex	NULL
from	NULL
BJA-B	NULL
cells	NULL
,	NULL
and	NULL
3	NULL
)	NULL
a	NULL
faster	NULL
migrating	NULL
DNA-protein	NULL
complex	NULL
termed	NULL
N-Oct-3	NULL
which	NULL
co-migrates	NULL
with	NULL
the	NULL
Oct-2C	NULL
complex	NULL
in	NULL
BJA-B	NULL
extracts	NULL
.	NULL

Unlike	NULL
lymphocyte	NULL
nuclear	NULL
extracts	NULL
,	NULL
none	NULL
of	NULL
the	NULL
extracts	NULL
from	NULL
the	NULL
different	NULL
human	NULL
nervous	NULL
system	NULL
cell	NULL
lines	NULL
displayed	NULL
the	NULL
Oct-2B	NULL
complex	NULL
.	NULL

It	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
distinguish	NULL
the	NULL
cell	NULL
lines	NULL
according	NULL
to	NULL
their	NULL
origin	NULL
as	NULL
neuroblastoma	NULL
,	NULL
glioblastoma	NULL
or	NULL
melanoma	NULL
based	NULL
on	NULL
the	NULL
composition	NULL
of	NULL
Oct-proteins	NULL
in	NULL
the	NULL
corresponding	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
Oct-1	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
nuclear	NULL
cell	NULL
extracts	NULL
of	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
;	NULL
the	NULL
combination	NULL
of	NULL
Oct-1	NULL
with	NULL
N-Oct-3	NULL
or	NULL
Oct-1	NULL
together	NULL
with	NULL
N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
was	NULL
observed	NULL
in	NULL
some	NULL
glioblastoma	NULL
and	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
.	NULL

None	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
expressed	NULL
N-Oct-2	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
N-Oct-3	NULL
.	NULL

In	NULL
COS-7	NULL
cells	NULL
,	NULL
L-cells	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
only	NULL
the	NULL
Oct-1	NULL
protein	NULL
was	NULL
detected	NULL
.	NULL

To	NULL
show	NULL
that	NULL
the	NULL
novel	NULL
complexes	NULL
detected	NULL
are	NULL
not	NULL
due	NULL
to	NULL
proteolytic	NULL
degradation	NULL
occuring	NULL
during	NULL
extract	NULL
preparation	NULL
with	NULL
these	NULL
particular	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
integrity	NULL
of	NULL
high	NULL
molecular	NULL
weight	NULL
proteins	NULL
in	NULL
these	NULL
extracts	NULL
by	NULL
comparative	NULL
SDS-polyacrylamide	NULL
electrophoresis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
comparative	NULL
bandshift	NULL
experiment	NULL
with	NULL
these	NULL
extracts	NULL
,	NULL
a	NULL
BJA-B	NULL
extract	NULL
,	NULL
and	NULL
an	NULL
Sp1-transcription	NULL
factor	NULL
binding	NULL
site	NULL
.	NULL

All	NULL
extracts	NULL
produced	NULL
bandshifts	NULL
characteristic	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
un-proteolyzed	NULL
Spl	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Presence	NULL
of	NULL
additional	NULL
N-Oct	NULL
proteins	NULL
in	NULL
extracts	NULL
from	NULL
cultured	NULL
astrocytes	NULL
To	NULL
rule	NULL
out	NULL
the	NULL
formal	NULL
possibility	NULL
that	NULL
the	NULL
novel	NULL
octamer	NULL
factors	NULL
were	NULL
only	NULL
detectable	NULL
in	NULL
long-term	NULL
cultured	NULL
human	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
tested	NULL
for	NULL
their	NULL
presence	NULL
in	NULL
extracts	NULL
from	NULL
cultured	NULL
astrocytes	NULL
derived	NULL
from	NULL
brains	NULL
of	NULL
newborn	NULL
mice	NULL
and	NULL
from	NULL
extracts	NULL
prepared	NULL
from	NULL
total	NULL
brain	NULL
of	NULL
adult	NULL
and	NULL
newborn	NULL
mice	NULL
.	NULL

We	NULL
included	NULL
in	NULL
this	NULL
experiment	NULL
a	NULL
rat	NULL
glioma	NULL
cell	NULL
line	NULL
(	NULL
C6	NULL
)	NULL
to	NULL
ask	NULL
whether	NULL
the	NULL
novel	NULL
Oct-complexes	NULL
are	NULL
conserved	NULL
inter-species	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1B	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
extract	NULL
from	NULL
the	NULL
C6	NULL
cells	NULL
also	NULL
produced	NULL
the	NULL
Oct-1	NULL
and	NULL
the	NULL
N-Oct-3	NULL
complex	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
,	NULL
three	NULL
more	NULL
complexes	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
astrocytes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
brain	NULL
extracts	NULL
(	NULL
lane	NULL
1	NULL
and	NULL
2	NULL
)	NULL
:	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
,	NULL
a	NULL
faint	NULL
complex	NULL
,	NULL
termed	NULL
N-Oct-4	NULL
,	NULL
running	NULL
below	NULL
N-Oct-3	NULL
,	NULL
and	NULL
two	NULL
fast	NULL
,	NULL
comigrating	NULL
complexes	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
N-Oct-S5a	NULL
and	NULL
N-Oct-5b	NULL
.	NULL

The	NULL
N-Oct-Sa/b	NULL
complexes	NULL
were	NULL
less	NULL
abundant	NULL
in	NULL
human	NULL
SK-N-BE	NULL
neuroblastoma	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
same	NULL
data	NULL
were	NULL
obtained	NULL
when	NULL
nuclear	NULL
extracts	NULL
were	NULL
taken	NULL
from	NULL
astrocyte	NULL
cultures	NULL
established	NULL
from	NULL
newborn	NULL
rats	NULL
as	NULL
described	NULL
by	NULL
Massa	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
astrocytes	NULL
,	NULL
but	NULL
not	NULL
the	NULL
various	NULL
glioblastoma	NULL
or	NULL
neuroblastoma	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
contain	NULL
the	NULL
full	NULL
spectrum	NULL
of	NULL
Oct-proteins	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
:	NULL
N-Oct-2	NULL
,	NULL
N-Oct-3	NULL
,	NULL
N-Oct-4	NULL
,	NULL
N-Oct-5a/b	NULL
and	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
protein	NULL
.	NULL

Identical	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
B-cell	NULL
derived	NULL
Oct-2	NULL
and	NULL
N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
The	NULL
specificity	NULL
of	NULL
the	NULL
octamer	NULL
DNA-protein	NULL
interactions	NULL
was	NULL
analyzed	NULL
by	NULL
competition	NULL
binding	NULL
experiments	NULL
.	NULL

A	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
unlabelled	NULL
oligonucleotide	NULL
containing	NULL
either	NULL
the	NULL
wildtype	NULL
octamer	NULL
sequence	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
or	NULL
a	NULL
mutated	NULL
octamer	NULL
(	NULL
CTGAACAT	NULL
)	NULL
was	NULL
used	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
radiolabelled	NULL
bandshift	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1C	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
Oct-1	NULL
,	NULL
N-Oct-2	NULL
,	NULL
N-Oct-3	NULL
and	NULL
N-Oct-5a/b	NULL
was	NULL
efficiently	NULL
competed	NULL
by	NULL
an	NULL
unlabelled	NULL
DNA	NULL
containing	NULL
the	NULL
genuine	NULL
octamer	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
7-12	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mutated	NULL
octamer	NULL
sequence	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
(	NULL
lanes	NULL
13-18	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
octamer	NULL
DNA	NULL
sequence	NULL
and	NULL
not	NULL
with	NULL
other	NULL
sequences	NULL
on	NULL
the	NULL
fragment	NULL
used	NULL
for	NULL
the	NULL
bandshift	NULL
experiments	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
contact	NULL
points	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
we	NULL
performed	NULL
a	NULL
methylation	NULL
interference	NULL
analysis	NULL
(	NULL
Siebenlist	NULL
and	NULL
Gilbert	NULL
,	NULL
1980	NULL
)	NULL
.	NULL

An	NULL
end-labelled	NULL
octamer	NULL
bandshift	NULL
probe	NULL
(	NULL
oligo	NULL
oct*/hep~	NULL
;	NULL
Kemler	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
was	NULL
partially	NULL
methylated	NULL
and	NULL
used	NULL
for	NULL
a	NULL
preparative	NULL
bandshift	NULL
assay	NULL
with	NULL
extracts	NULL
from	NULL
SK-N-BE	NULL
and	NULL
from	NULL
BJA-B	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
N-Oct-3	NULL
complex	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
prevented	NULL
by	NULL
methylation	NULL
over	NULL
the	NULL
same	NULL
nucleotides	NULL
of	NULL
the	NULL
octamer	NULL
region	NULL
as	NULL
for	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
BJA-B	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
therefore	NULL
that	NULL
the	NULL
mode	NULL
of	NULL
DNA	NULL
recognition	NULL
is	NULL
the	NULL
same	NULL
for	NULL
all	NULL
three	NULL
octamer	NULL
binding	NULL
proteins	NULL
tested	NULL
.	NULL

«	NULL
ith	NULL
«	NULL
ik	NULL
-	NULL
am	NULL
<	NULL
dh	NULL
«	NULL
«	NULL
«	NULL
itn	NULL
dh	NULL
P	NULL
]	NULL
Figure	NULL
2	NULL
:	NULL
Autoradiograph	NULL
of	NULL
a	NULL
methylation	NULL
interference	NULL
analysis	NULL
with	NULL
the	NULL
radiolabelled	NULL
octamer	NULL
bandshift	NULL
probe	NULL
and	NULL
Oct-2A	NULL
from	NULL
B-cells	NULL
,	NULL
N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
proteins	NULL
from	NULL
SK-N-BE	NULL
cells	NULL
reveals	NULL
identical	NULL
contact	NULL
sites	NULL
over	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

The	NULL
nucleotides	NULL
the	NULL
methylation	NULL
of	NULL
which	NULL
completely	NULL
or	NULL
partially	NULL
interferes	NULL
with	NULL
protein	NULL
binding	NULL
are	NULL
indicated	NULL
by	NULL
solid	NULL
or	NULL
open	NULL
triangles	NULL
,	NULL
respectively	NULL
.	NULL

Isolation	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
from	NULL
neuroblastoma	NULL
cells	NULL
Preparative	NULL
SDS-PAGE	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
subsequent	NULL
recovery	NULL
and	NULL
renaturation	NULL
of	NULL
size-separated	NULL
proteins	NULL
is	NULL
a	NULL
simple	NULL
and	NULL
straightforward	NULL
method	NULL
to	NULL
isolate	NULL
and	NULL
compare	NULL
different	NULL
octamer	NULL
binding	NULL
proteins	NULL
(	NULL
Schreiber	NULL
et	NULL
al.1988	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
from	NULL
SK-N-BE	NULL
neuroblastoma	NULL
cells	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
12	NULL
%	NULL
SDS-protein	NULL
gel	NULL
.	NULL

The	NULL
Oct-1	NULL
binding	NULL
activity	NULL
eluted	NULL
from	NULL
a	NULL
region	NULL
of	NULL
the	NULL
SDS-PAGE	NULL
gel	NULL
corresponding	NULL
to	NULL
a	NULL
MW	NULL
of	NULL
90-100	NULL
kDa	NULL
.	NULL

This	NULL
value	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
published	NULL
data	NULL
(	NULL
Fletcher	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

The	NULL
N-Oct-2	NULL
binding	NULL
activity	NULL
eluted	NULL
from	NULL
a	NULL
region	NULL
around	NULL
60	NULL
kDa	NULL
(	NULL
+/-	NULL
5	NULL
kDa	NULL
)	NULL
and	NULL
the	NULL
N-Oct-3	NULL
binding	NULL
activity	NULL
eluted	NULL
from	NULL
a	NULL
region	NULL
around	NULL
50	NULL
kDa	NULL
(	NULL
+/-	NULL
5	NULL
kDa	NULL
)	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
extensive	NULL
efforts	NULL
,	NULL
we	NULL
did	NULL
not	NULL
succeed	NULL
in	NULL
achieving	NULL
renaturation	NULL
of	NULL
the	NULL
N-Oct-4	NULL
and	NULL
the	NULL
N-Oct-5	NULL
complexes	NULL
.	NULL

Figure	NULL
3A	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
shows	NULL
an	NULL
autoradiograph	NULL
of	NULL
a	NULL
bandshift	NULL
experiment	NULL
with	NULL
renatured	NULL
Oct-proteins	NULL
isolated	NULL
from	NULL
SK-N-BE	NULL
neuroblastoma	NULL
cells	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
Oct-proteins	NULL
DNA	NULL
interactions	NULL
was	NULL
demonstrated	NULL
by	NULL
binding	NULL
competition	NULL
analysis	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
unlabelled	NULL
wildtype	NULL
octamer	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
and	NULL
an	NULL
otherwise	NULL
identical	NULL
DNA	NULL
fragment	NULL
which	NULL
contained	NULL
a	NULL
mutated	NULL
octamer	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
appeared	NULL
to	NULL
consist	NULL
of	NULL
two	NULL
independent	NULL
binding	NULL
activities	NULL
which	NULL
migrated	NULL
closely	NULL
together	NULL
when	NULL
tested	NULL
under	NULL
native	NULL
conditions	NULL
(	NULL
see	NULL
Figure	NULL
1	NULL
)	NULL
but	NULL
were	NULL
clearly	NULL
separable	NULL
after	NULL
physical	NULL
separation	NULL
on	NULL
a	NULL
denaturing	NULL
gel	NULL
and	NULL
subsequent	NULL
renaturation	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
a	NULL
low	NULL
MW	NULL
component	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
complex	NULL
during	NULL
the	NULL
denaturation/separation	NULL
process	NULL
.	NULL

We	NULL
have	NULL
tentatively	NULL
designated	NULL
the	NULL
proteins	NULL
responsible	NULL
for	NULL
the	NULL
slower	NULL
migrating	NULL
component	NULL
and	NULL
faster	NULL
migrating	NULL
complexes	NULL
as	NULL
N-Oct-Z2	NULL
«	NULL
and	NULL
N-Oct-2	NULL
$	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
latter	NULL
protein	NULL
was	NULL
also	NULL
present	NULL
in	NULL
the	NULL
gel	NULL
eluate	NULL
containing	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
.	NULL

Combination	NULL
of	NULL
both	NULL
gel	NULL
slice	NULL
eluates	NULL
yielded	NULL
an	NULL
additive	NULL
increase	NULL
in	NULL
N-Oct-2	NULL
(	NULL
binding	NULL
activity	NULL
;	NULL
the	NULL
same	NULL
result	NULL
was	NULL
seen	NULL
when	NULL
both	NULL
(	NULL
still	NULL
unrenatured	NULL
)	NULL
protein	NULL
eluates	NULL
were	NULL
co-renatured	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
seen	NULL
in	NULL
the	NULL
extracts	NULL
of	NULL
astrocytes	NULL
and	NULL
some	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
consists	NULL
of	NULL
two	NULL
A	NULL
{	NULL
&	NULL
&	NULL
®	NULL
I~	NULL
ato	NULL
i	NULL
>	NULL
me	NULL
ie	NULL
A	NULL
oo	NULL
of	NULL
CEC	NULL
oC	NULL
o*	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
in	NULL
kkkkk	NULL
a	NULL
wa	NULL
a-	NULL
ct-20	NULL
.	NULL

&	NULL
``	NULL
;	NULL
z	NULL
8B	NULL
we	NULL
<	NULL
-	NULL
NOct-23	NULL
N-Oct3	NULL
no	NULL
octamer	NULL
mutated	NULL
competitor	NULL
competitor	NULL
octamer	NULL
DNA	NULL
DNA	NULL
competitor	NULL
DNA	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
5499	NULL
separable	NULL
entities	NULL
with	NULL
MW	NULL
of	NULL
ca	NULL
.	NULL

60	NULL
kDa	NULL
each	NULL
,	NULL
namely	NULL
N-Oct-2	NULL
«	NULL
and	NULL
N-Oct-2	NULL
(	NULL
@	NULL
.	NULL

N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
also	NULL
bind	NULL
to	NULL
the	NULL
heptamer	NULL
element	NULL
of	NULL
the	NULL
IgH	NULL
promoter	NULL
A	NULL
characteristic	NULL
feature	NULL
of	NULL
known	NULL
Oct-proteins	NULL
is	NULL
their	NULL
remarkable	NULL
flexibility	NULL
in	NULL
binding	NULL
site	NULL
recognition	NULL
(	NULL
Sturm	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Thali	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

The	NULL
Oct-1	NULL
and	NULL
Oct-2A/B	NULL
proteins	NULL
do	NULL
not	NULL
only	NULL
bind	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
,	NULL
but	NULL
also	NULL
to	NULL
the	NULL
unrelated	NULL
heptamer	NULL
motif	NULL
CTCATGA	NULL
present	NULL
in	NULL
the	NULL
IgH	NULL
gene	NULL
promoter	NULL
,	NULL
though	NULL
with	NULL
lower	NULL
affinity	NULL
(	NULL
Poellinger	NULL
and	NULL
Roeder,1989	NULL
;	NULL
Kemler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
the	NULL
novel	NULL
Oct-proteins	NULL
present	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
cells	NULL
are	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
heptamer	NULL
sequence	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
incubated	NULL
a	NULL
radiolabelled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
heptamer	NULL
element	NULL
and	NULL
a	NULL
mutated	NULL
octamer	NULL
sequence	NULL
(	NULL
hep*	NULL
oct~	NULL
;	NULL
Kemler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
with	NULL
renatured	NULL
fractions	NULL
from	NULL
size-separated	NULL
octamer	NULL
binding	NULL
proteins	NULL
derived	NULL
from	NULL
SK-N-BE	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3B	NULL
,	NULL
the	NULL
neuroblastoma	NULL
derived	NULL
Oct-1	NULL
,	NULL
N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
proteins	NULL
can	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
heptamer	NULL
motif	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
display	NULL
the	NULL
same	NULL
feature	NULL
of	NULL
heterologous	NULL
sequence	NULL
recognition	NULL
as	NULL
the	NULL
Oct-proteins	NULL
from	NULL
B-lymphocytes	NULL
.	NULL

The	NULL
N-Oct-protein	NULL
:	NULL
heptamer-DNA	NULL
interaction	NULL
was	NULL
efficiently	NULL
competed	NULL
with	NULL
excess	NULL
of	NULL
unlabelled	NULL
DNA	NULL
with	NULL
an	NULL
octamer-	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
but	NULL
not	NULL
with	NULL
a	NULL
DNA	NULL
fragment	NULL
containing	NULL
a	NULL
mutated	NULL
octamer	NULL
sequence	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Oct-2A	NULL
from	NULL
B-cells	NULL
is	NULL
different	NULL
from	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
By	NULL
using	NULL
the	NULL
proteolytic	NULL
clipping	NULL
bandshift	NULL
assay	NULL
technique	NULL
(	NULL
Marzouki	NULL
et	NULL
al	NULL
.	NULL

1986	NULL
)	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
distinguish	NULL
the	NULL
three	NULL
major	NULL
forms	NULL
of	NULL
octamer	NULL
DNA	NULL
binding	NULL
proteins	NULL
detected	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
B-cells	NULL
comigrates	NULL
with	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
in	NULL
a	NULL
bandshift	NULL
gel	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
Oct-2A	NULL
protein	NULL
is	NULL
related	NULL
to	NULL
the	NULL
a	NULL
or	NULL
{	NULL
-form	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
BJA-B	NULL
cells	NULL
and	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
from	NULL
SK-N-BE	NULL
cells	NULL
were	NULL
isolated	NULL
following	NULL
SDS-PAGE	NULL
,	NULL
renatured	NULL
,	NULL
and	NULL
,	NULL
after	NULL
a	NULL
preincubation	NULL
in	NULL
a	NULL
bandshift	NULL
binding	NULL
reaction	NULL
,	NULL
exposed	NULL
to	NULL
defined	NULL
heptamer	NULL
___	NULL
probe	NULL
no	NULL
octamer	NULL
mutated	NULL
competitor	NULL
__	NULL
competitor	NULL
octamer	NULL
DNA	NULL
DNA	NULL
competitor	NULL
DNA	NULL
Figure	NULL
3A	NULL
:	NULL
Autoradiograph	NULL
of	NULL
a	NULL
bandshift	NULL
experiment	NULL
after	NULL
separation	NULL
of	NULL
N-Oct-2	NULL
«	NULL
/28	NULL
and	NULL
N-Oct-3	NULL
by	NULL
preparative	NULL
SDS-PAGE	NULL
and	NULL
renaturation	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
SK-N-BE	NULL
neuroblastoma	NULL
cells	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
denaturing	NULL
protein	NULL
gel	NULL
;	NULL
after	NULL
cutting	NULL
the	NULL
gel	NULL
into	NULL
slices	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
denaturation/renaturation	NULL
protocol	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
three	NULL
octamer	NULL
DNA	NULL
binding	NULL
complexes	NULL
detected	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
Oct-1	NULL
,	NULL
N-Oct-2	NULL
«	NULL
/28	NULL
and	NULL
N-Oct-3	NULL
,	NULL
were	NULL
used	NULL
for	NULL
a	NULL
competition	NULL
experiment	NULL
as	NULL
described	NULL
in	NULL
legend	NULL
to	NULL
Figure	NULL
1C	NULL
.	NULL

Figure	NULL
3B	NULL
:	NULL
N-Oct-proteins	NULL
bind	NULL
also	NULL
to	NULL
the	NULL
heptamer	NULL
element	NULL
of	NULL
the	NULL
IgH	NULL
promoter	NULL
.	NULL

Isolated	NULL
N-Oct-2	NULL
«	NULL
/28	NULL
and	NULL
N-Oct-3	NULL
protein	NULL
(	NULL
see	NULL
Figure	NULL
3A	NULL
)	NULL
were	NULL
tested	NULL
by	NULL
bandshift	NULL
assay	NULL
using	NULL
a	NULL
radiolabelled	NULL
heptamer	NULL
motif	NULL
(	NULL
see	NULL
Material	NULL
and	NULL
Methods	NULL
)	NULL
and	NULL
either	NULL
intact	NULL
or	NULL
mutated	NULL
octamer	NULL
competitor	NULL
DNAs	NULL
as	NULL
described	NULL
in	NULL
legend	NULL
to	NULL
Figure	NULL
1C	NULL
.	NULL

5500	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
amounts	NULL
of	NULL
trypsin	NULL
which	NULL
cleaves	NULL
proteins	NULL
after	NULL
arginine	NULL
or	NULL
lysine	NULL
residues	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
trypsin	NULL
clipped	NULL
the	NULL
Oct-2A	NULL
protein	NULL
of	NULL
BJA-B	NULL
cells	NULL
into	NULL
five	NULL
polypeptides	NULL
.	NULL

Even	NULL
though	NULL
the	NULL
degradation	NULL
pattern	NULL
of	NULL
the	NULL
neuroblastoma	NULL
N-Oct-2	NULL
complex	NULL
differed	NULL
somewhat	NULL
from	NULL
that	NULL
of	NULL
Oct-2A	NULL
,	NULL
note	NULL
that	NULL
three	NULL
small	NULL
truncated	NULL
polypeptides	NULL
(	NULL
most	NULL
probably	NULL
derived	NULL
from	NULL
N-Oct-2	NULL
«	NULL
)	NULL
comigrate	NULL
with	NULL
peptides	NULL
derived	NULL
from	NULL
the	NULL
Oct-Z2A	NULL
protein	NULL
.	NULL

Although	NULL
the	NULL
N-Oct-2	NULL
(	NULL
3	NULL
protein	NULL
seems	NULL
to	NULL
be	NULL
more	NULL
resistant	NULL
to	NULL
trypsin	NULL
than	NULL
N-Oct-2	NULL
«	NULL
its	NULL
contribution	NULL
to	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
fragments	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

We	NULL
are	NULL
therefore	NULL
unable	NULL
at	NULL
this	NULL
point	NULL
to	NULL
assess	NULL
its	NULL
contribution	NULL
to	NULL
the	NULL
clipping	NULL
pattern	NULL
seen	NULL
in	NULL
Figure	NULL
4A	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
N-Oct-2	NULL
«	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
both	NULL
N-Oct	NULL
2	NULL
proteins	NULL
are	NULL
distinct	NULL
from	NULL
the	NULL
Oct-2A	NULL
protein	NULL
of	NULL
B-cells	NULL
.	NULL

We	NULL
next	NULL
used	NULL
the	NULL
ArgC	NULL
protease	NULL
,	NULL
which	NULL
cleaves	NULL
proteins	NULL
specifically	NULL
after	NULL
arginine	NULL
residues	NULL
,	NULL
to	NULL
analyze	NULL
the	NULL
relationship	NULL
between	NULL
Oct-2A	NULL
from	NULL
B-cells	NULL
and	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
from	NULL
Bowes	NULL
melanocytes	NULL
.	NULL

Figure	NULL
4B	NULL
shows	NULL
that	NULL
the	NULL
clipping	NULL
pattern	NULL
exhibited	NULL
by	NULL
N-Oct-3	NULL
was	NULL
seemingly	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Oct-2A	NULL
.	NULL

The	NULL
change	NULL
in	NULL
the	NULL
molecular	NULL
weights	NULL
of	NULL
the	NULL
two	NULL
different	NULL
polypeptides	NULL
due	NULL
to	NULL
the	NULL
action	NULL
of	NULL
ArgC	NULL
is	NULL
the	NULL
same	NULL
,	NULL
even	NULL
though	NULL
the	NULL
starting	NULL
molecular	NULL
weights	NULL
are	NULL
dissimilar	NULL
.	NULL

This	NULL
observation	NULL
can	NULL
be	NULL
interpreted	NULL
to	NULL
mean	NULL
that	NULL
both	NULL
proteins	NULL
contain	NULL
a	NULL
homologous	NULL
domain	NULL
that	NULL
is	NULL
removed	NULL
upon	NULL
ArgC	NULL
digestion	NULL
.	NULL

However	NULL
,	NULL
the	NULL
Oct-2A	NULL
protein	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
sensitive	NULL
towards	NULL
ArgC	NULL
proteolysis	NULL
than	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
.	NULL

A	NULL
similar	NULL
lower	NULL
sensitivity	NULL
to	NULL
ArgC	NULL
proteolysis	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
in	NULL
SK-N-BE	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
relation	NULL
between	NULL
these	NULL
proteins	NULL
remains	NULL
an	NULL
open	NULL
question	NULL
.	NULL

The	NULL
Oct-1	NULL
complex	NULL
from	NULL
extracts	NULL
of	NULL
Bowes	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
and	NULL
SK-N-BE	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
identical	NULL
with	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
protein	NULL
since	NULL
it	NULL
displayed	NULL
the	NULL
same	NULL
degradation	NULL
pattern	NULL
as	NULL
that	NULL
described	NULL
for	NULL
the	NULL
Oct-1	NULL
protein	NULL
of	NULL
HeLa	NULL
and	NULL
BJA-B	NULL
cells	NULL
(	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

Antibodies	NULL
directed	NULL
against	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
do	NULL
not	NULL
recognize	NULL
N-Oct	NULL
proteins	NULL
To	NULL
further	NULL
investigate	NULL
the	NULL
relationship	NULL
of	NULL
N-Oct-factors	NULL
to	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
we	NULL
used	NULL
antisera	NULL
raised	NULL
against	NULL
recombinant	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
proteins	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
BJA-B	NULL
.	NULL

lymphocytes	NULL
,	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
,	NULL
and	NULL
from	NULL
astrocytes	NULL
were	NULL
preincubated	NULL
A	NULL
l_	NULL
i	NULL
<	NULL
-¢	NULL
.	NULL

HH	NULL
HHH	NULL
with	NULL
dilutions	NULL
of	NULL
either	NULL
antiserum	NULL
and	NULL
then	NULL
tested	NULL
for	NULL
octamer-DNA	NULL
sequence	NULL
binding	NULL
.	NULL

From	NULL
Figure	NULL
5A	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
the	NULL
anti-Oct-l-antibodies	NULL
specifically	NULL
affected	NULL
DNA-binding	NULL
of	NULL
the	NULL
Oct-1	NULL
protein	NULL
.	NULL

Neither	NULL
the	NULL
B-cell	NULL
type	NULL
factors	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
nor	NULL
the	NULL
N-Oct	NULL
factors	NULL
were	NULL
neutralized	NULL
.	NULL

The	NULL
preimmune	NULL
serum	NULL
did	NULL
not	NULL
affect	NULL
any	NULL
of	NULL
the	NULL
Oct-proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
used	NULL
the	NULL
anti-Oct-2-antibodies	NULL
:	NULL
Figure	NULL
5B	NULL
shows	NULL
that	NULL
all	NULL
N-Oct	NULL
factors	NULL
and	NULL
Oct-1	NULL
remained	NULL
unaffected	NULL
in	NULL
DNA-binding	NULL
and	NULL
migration	NULL
even	NULL
at	NULL
high	NULL
antiserum	NULL
concentrations	NULL
,	NULL
whereas	NULL
virtually	NULL
all	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
Oct-2A	NULL
and	NULL
(	NULL
less	NULL
pronounced	NULL
)	NULL
of	NULL
Oct-2B	NULL
proteins	NULL
were	NULL
affected	NULL
.	NULL

The	NULL
interactions	NULL
of	NULL
the	NULL
antibodies	NULL
with	NULL
Oct-2	NULL
gave	NULL
rise	NULL
to	NULL
high	NULL
molecular	NULL
weight	NULL
complexes	NULL
and	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
the	NULL
antiserum	NULL
to	NULL
elimination	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
all	NULL
N-Oct	NULL
proteins	NULL
do	NULL
not	NULL
contain	NULL
epitopes	NULL
which	NULL
can	NULL
be	NULL
recognized	NULL
by	NULL
the	NULL
two	NULL
polyclonal	NULL
antisera	NULL
directed	NULL
against	NULL
the	NULL
Oct-1	NULL
and	NULL
the	NULL
Oct-2	NULL
proteins	NULL
respectively	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
N-Oct	NULL
proteins	NULL
are	NULL
most	NULL
likely	NULL
structurally	NULL
different	NULL
from	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

Transcription	NULL
from	NULL
a	NULL
B	NULL
cell-specific	NULL
promoter	NULL
is	NULL
not	NULL
stimulated	NULL
in	NULL
N-Oct-3	NULL
containing	NULL
Bowes	NULL
melanocytes	NULL
The	NULL
octamer	NULL
sequence	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
TATA	NULL
box	NULL
constitutes	NULL
a	NULL
B-cell	NULL
specific	NULL
promoter	NULL
(	NULL
Dreyfus	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
,	NULL
Wirth	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
,	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

A	NULL
simple	NULL
model	NULL
proposes	NULL
that	NULL
the	NULL
transcription	NULL
activation	NULL
potential	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
Oct-2A	NULL
protein	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
this	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
protein	NULL
is	NULL
only	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
conjunction	NULL
with	NULL
an	NULL
additional	NULL
,	NULL
closely	NULL
bound	NULL
transcription	NULL
factor	NULL
(	NULL
reviewed	NULL
in	NULL
Schaffner,1989	NULL
)	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
in	NULL
Bowes	NULL
melanocytes	NULL
is	NULL
able	NULL
to	NULL
'transactivate	NULL
'	NULL
such	NULL
a	NULL
minimal	NULL
,	NULL
B-cell	NULL
specific	NULL
promoter	NULL
.	NULL

Bowes	NULL
melanocytes	NULL
(	NULL
containing	NULL
Oct-1	NULL
and	NULL
N-Oct-3	NULL
)	NULL
and	NULL
Cos7	NULL
kidney	NULL
fibroblasts	NULL
(	NULL
containing	NULL
only	NULL
Oct-1	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
target	NULL
plasmids	NULL
outlined	NULL
in	NULL
Figure	NULL
6	NULL
.	NULL

Construct	NULL
A	NULL
contains	NULL
the	NULL
octamer	NULL
sequence	NULL
separated	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
B-globin	NULL
reporter	NULL
gene	NULL
by	NULL
5	NULL
bp	NULL
.	NULL

Construct	NULL
B	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mutated	NULL
octamer	NULL
sequence	NULL
,	NULL
and	NULL
construct	NULL
C	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
wild-type	NULL
3-globin	NULL
promoter	NULL
,	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
transient	NULL
expression	NULL
of	NULL
these	NULL
constructs	NULL
,	NULL
the	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
reporter	NULL
B	NULL
Us	NULL
us	NULL
C	NULL
#	NULL
as	NULL
«	NULL
-	NULL
@	NULL
pres	NULL
«	NULL
*	NULL
IP	NULL
«	NULL
»	NULL
«	NULL
--	NULL
up	NULL
C	NULL
oud	NULL
Figure	NULL
4A	NULL
:	NULL
Autoradiograph	NULL
of	NULL
a	NULL
proteolytic	NULL
clipping	NULL
bandshift	NULL
analysis	NULL
.	NULL

The	NULL
SDS-PAGE	NULL
purified	NULL
Oct-2A	NULL
protein	NULL
from	NULL
B-cells	NULL
and	NULL
N-Oct-2	NULL
«	NULL
and	NULL
8	NULL
from	NULL
SK-N-BE	NULL
cells	NULL
were	NULL
pre-incubated	NULL
with	NULL
the	NULL
radiolabelled	NULL
bandshift	NULL
probe	NULL
and	NULL
subjected	NULL
to	NULL
limited	NULL
proteolysis	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
trypsin	NULL
.	NULL

After	NULL
10	NULL
min	NULL
.	NULL

the	NULL
'bandshift'/protease	NULL
mixture	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
bandshift	NULL
gel	NULL
.	NULL

The	NULL
clipping	NULL
pattern	NULL
is	NULL
illustrated	NULL
schematically	NULL
on	NULL
the	NULL
right	NULL
hand	NULL
side	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
band	NULL
seen	NULL
with	NULL
N-Oct-2	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
trypsin	NULL
is	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
N-Oct-2	NULL
.	NULL

Figure	NULL
4B	NULL
:	NULL
Proteolytic	NULL
clipping	NULL
bandshift	NULL
analysis	NULL
of	NULL
Oct-proteins	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
ArgC	NULL
protease	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Oct-2A	NULL
cDNA	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
(	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
and	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
schematic	NULL
drawing	NULL
illustrates	NULL
the	NULL
clipping	NULL
pattern	NULL
of	NULL
the	NULL
Oct-2A	NULL
and	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
.	NULL

transcripts	NULL
monitored	NULL
by	NULL
RNase	NULL
protection	NULL
mapping	NULL
.	NULL

Figure	NULL
6	NULL
shows	NULL
that	NULL
the	NULL
B	NULL
cell-specific	NULL
octamer-TATA	NULL
promoter	NULL
(	NULL
construct	NULL
A	NULL
)	NULL
remained	NULL
silent	NULL
in	NULL
Bowes	NULL
melanocytes	NULL
as	NULL
well	NULL
as	NULL
in	NULL
Cos7	NULL
cells	NULL
.	NULL

To	NULL
exclude	NULL
a	NULL
possible	NULL
repressor	NULL
function	NULL
of	NULL
N-Oct	NULL
3	NULL
perhaps	NULL
analogous	NULL
to	NULL
the	NULL
one	NULL
proposed	NULL
for	NULL
NF-A	NULL
III	NULL
(	NULL
Lenardo	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
,	NULL
we	NULL
co-transfected	NULL
construct	NULL
A	NULL
and	NULL
the	NULL
Oct-2A	NULL
cDNA	NULL
in	NULL
an	NULL
expression	NULL
vector	NULL
(	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

1988b	NULL
)	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
an	NULL
activation	NULL
of	NULL
this	NULL
promoter	NULL
comparable	NULL
to	NULL
the	NULL
strong	NULL
activation	NULL
seen	NULL
with	NULL
the	NULL
promoter	NULL
(	NULL
construct	NULL
C	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
,	NULL
in	NULL
the	NULL
amounts	NULL
present	NULL
in	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
,	NULL
is	NULL
neither	NULL
competent	NULL
to	NULL
'transactivate	NULL
'	NULL
a	NULL
simple	NULL
octamer-TATA	NULL
promoter	NULL
nor	NULL
to	NULL
prevent	NULL
promoter	NULL
activation	NULL
by	NULL
the	NULL
Oct-2A	NULL
protein	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
work	NULL
shows	NULL
that	NULL
the	NULL
nervous	NULL
system	NULL
expresses	NULL
a	NULL
set	NULL
of	NULL
Oct-proteins	NULL
which	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
expressed	NULL
by	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

The	NULL
nervous	NULL
system	NULL
derived	NULL
octamer	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
designated	NULL
as	NULL
Oct-1	NULL
(	NULL
the	NULL
ubiquitous	NULL
species	NULL
)	NULL
,	NULL
N-Oct-2a	NULL
«	NULL
and	NULL
28	NULL
,	NULL
N-Oct-3	NULL
,	NULL
N-Oct-4	NULL
and	NULL
N-Oct-5a/5b	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
mobility	NULL
in	NULL
the	NULL
bandshift	NULL
assay	NULL
.	NULL

While	NULL
this	NULL
work	NULL
was	NULL
in	NULL
progress	NULL
,	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
published	NULL
an	NULL
overview	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
from	NULL
extracts	NULL
of	NULL
various	NULL
tissues	NULL
including	NULL
brain	NULL
of	NULL
mouse	NULL
and	NULL
rat	NULL
.	NULL

A	NULL
similar	NULL
picture	NULL
was	NULL
seen	NULL
with	NULL
A	NULL
B-cell	NULL
_	NULL
Melanoma	NULL
Astrocytes	NULL
we	NULL
Oct-1	NULL
_	NULL
-	NULL
»	NULL
we	NULL
u	NULL
-=-	NULL
Oct-1	NULL
Oct-2B	NULL
»	NULL
g	NULL
Oct-2A	NULL
-	NULL
»	NULL
was	NULL
er	NULL
--	NULL
N-Oct2	NULL
(	NULL
;	NULL
tne	NULL
ae	NULL
wes	NULL
was	NULL
--	NULL
N-Oct3	NULL
-=-	NULL
N-Oct4	NULL
wwe	NULL
wan	NULL
--	NULL
N-Oct5	NULL
]	NULL
,	NULL
w-	NULL
_	NULL
usan	NULL
WAW	NULL
-	NULL
oF	NULL
o-	NULL
<	NULL
+	NULL
anti	NULL
-	NULL
Oct-1	NULL
-	NULL
serum	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
5501	NULL
the	NULL
bandshift	NULL
assay	NULL
;	NULL
in	NULL
their	NULL
nomenclature	NULL
the	NULL
Oct-2	NULL
band	NULL
corresponds	NULL
to	NULL
our	NULL
N-Oct-2	NULL
complex	NULL
,	NULL
Oct-3	NULL
to	NULL
N-Oct-3	NULL
,	NULL
Oct-7	NULL
to	NULL
N-Oct-4	NULL
and	NULL
Oct9/10	NULL
to	NULL
N-Oct	NULL
Sa/b	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
differential	NULL
distribution	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
both	NULL
astrocytes	NULL
and	NULL
tumor	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

Further	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
DNA	NULL
binding	NULL
characteristics	NULL
of	NULL
the	NULL
N-Oct-2	NULL
and	NULL
N-Oct-3	NULL
proteins	NULL
and	NULL
analyzed	NULL
their	NULL
relationship	NULL
to	NULL
the	NULL
Oct-proteins	NULL
from	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
role	NULL
of	NULL
N-Oct-3	NULL
as	NULL
a	NULL
putative	NULL
transcription	NULL
factor	NULL
.	NULL

B-cell	NULL
and	NULL
nervous	NULL
system	NULL
derived	NULL
Oct-proteins	NULL
have	NULL
indistinguishable	NULL
features	NULL
of	NULL
DNA-binding	NULL
The	NULL
nuclear	NULL
proteins	NULL
from	NULL
nervous	NULL
system	NULL
cells	NULL
share	NULL
the	NULL
same	NULL
properties	NULL
of	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
as	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
protein	NULL
and	NULL
the	NULL
lymphoid-prominent	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
proteins	NULL
by	NULL
several	NULL
criteria	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
N-Oct	NULL
proteins	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
was	NULL
competed	NULL
efficiently	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
octamer	NULL
binding	NULL
site	NULL
,	NULL
but	NULL
was	NULL
not	NULL
affected	NULL
when	NULL
the	NULL
binding	NULL
site	NULL
was	NULL
mutated	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
share	NULL
a	NULL
60	NULL
amino	NULL
acid	NULL
region	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
homeodomain	NULL
,	NULL
first	NULL
described	NULL
in	NULL
factors	NULL
regulating	NULL
early	NULL
development	NULL
in	NULL
Drosophila	NULL
,	NULL
and	NULL
by	NULL
the	NULL
adjacent	NULL
region	NULL
,	NULL
designated	NULL
the	NULL
POU-specific	NULL
domain	NULL
.	NULL

The	NULL
POU-domain	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
the	NULL
transcriptional	NULL
activators	NULL
Pit-1	NULL
,	NULL
a	NULL
factor	NULL
essential	NULL
for	NULL
prolactin	NULL
and	NULL
growth	NULL
B-cell	NULL
Melanoma	NULL
Astrocytes	NULL
wane	NULL
sone	NULL
was	NULL
Nit	NULL
lg	NULL
”	NULL
--	NULL
0-woe	NULL
wr	NULL
man	NULL
tth	NULL
wae	NULL
»	NULL
-	NULL
.	NULL

a	NULL
6	NULL
0	NULL
005	NULL
025	NULL
O5	NULL
15	NULL
0	NULL
005	NULL
025	NULL
05	NULL
15	NULL
0	NULL
005	NULL
025	NULL
05	NULL
15	NULL
ul	NULL
anti	NULL
-	NULL
Oct-2	NULL
-	NULL
serum	NULL
Figure	NULL
5A	NULL
:	NULL
Autoradiograph	NULL
of	NULL
a	NULL
bandshift	NULL
analysis	NULL
showing	NULL
that	NULL
anti-Oct-l-antibodies	NULL
eliminated	NULL
DNA-binding	NULL
of	NULL
Oct-1	NULL
but	NULL
not	NULL
of	NULL
N-Oct	NULL
proteins	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
241	NULL
)	NULL
from	NULL
BJA-B	NULL
lymphocytes	NULL
,	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
,	NULL
and	NULL
from	NULL
mouse	NULL
astrocytes	NULL
were	NULL
preincubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
1	NULL
ul	NULL
of	NULL
anti-Oct-l-antibodies	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
DNA	NULL
.	NULL

Figure	NULL
5B	NULL
:	NULL
Antibodies	NULL
against	NULL
the	NULL
Oct-2A	NULL
protein	NULL
do	NULL
not	NULL
recognize	NULL
N-Oct	NULL
proteins	NULL
.	NULL

Autoradiograph	NULL
of	NULL
a	NULL
bandshift	NULL
analysis	NULL
showing	NULL
a	NULL
titration	NULL
of	NULL
anti-Oct-Z-antibodies	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA-B	NULL
lymphocytes	NULL
,	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
and	NULL
from	NULL
mouse	NULL
astrocytes	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
antiserum	NULL
is	NULL
indicated	NULL
(	NULL
in	NULL
L1	NULL
)	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

A	NULL
B	NULL
C	NULL
A	NULL
B	NULL
C	NULL
reporter	NULL
gene	NULL
wite	NULL
transcript	NULL
Co	NULL
reference	NULL
gene	NULL
--	NULL
-	NULL
©	NULL
us	NULL
greg	NULL
n	NULL
82	NULL
transcripts	NULL
___	NULL
-*	NULL
**	NULL
@	NULL
@	NULL
@	NULL
we	NULL
»	NULL
.	NULL

‘	NULL
patil	NULL
nize	NULL
sel	NULL
Bowes	NULL
Cos	NULL
7	NULL
B	NULL
A	NULL
--	NULL
@	NULL
-mm-C	NULL
--	NULL
-svao-	NULL
B	NULL
B	NULL
——	NULL
;	NULL
§§—TATA—b—	NULL
Sv4ao-	NULL
B	NULL
(	NULL
--	NULL
-	NULL
B-globin	NULL
promb—	NULL
SV40	NULL
Figure	NULL
6	NULL
:	NULL
Autoradiograph	NULL
of	NULL
an	NULL
RNase	NULL
protection	NULL
mapping	NULL
of	NULL
transfected	NULL
(	NULL
3-globin	NULL
test	NULL
and	NULL
reference	NULL
genes	NULL
in	NULL
Bowes	NULL
melanoma	NULL
and	NULL
COS-7	NULL
cells	NULL
.	NULL

The	NULL
test	NULL
plasmids	NULL
are	NULL
schematically	NULL
outlined	NULL
on	NULL
the	NULL
right	NULL
hand	NULL
side	NULL
and	NULL
are	NULL
further	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

The	NULL
upper	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
protected	NULL
signal	NULL
of	NULL
the	NULL
test	NULL
gene	NULL
and	NULL
the	NULL
lower	NULL
arrows	NULL
to	NULL
the	NULL
signal	NULL
of	NULL
the	NULL
cotransfected	NULL
reference	NULL
gene	NULL
.	NULL

5502	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
hormone	NULL
gene	NULL
expression	NULL
in	NULL
pituitary	NULL
cells	NULL
(	NULL
Ingraham	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
,	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
and	NULL
the	NULL
Caenorhabditis	NULL
gene	NULL
unc-86	NULL
(	NULL
reviewed	NULL
in	NULL
Herr	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
and	NULL
Garcia-Blanco	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

The	NULL
methylation	NULL
interference	NULL
pattern	NULL
generated	NULL
on	NULL
the	NULL
octamer	NULL
sequence	NULL
is	NULL
identical	NULL
for	NULL
N-Oct-2	NULL
proteins	NULL
,	NULL
N-Oct-3	NULL
,	NULL
and	NULL
Oct-2A	NULL
.	NULL

Furthermore	NULL
,	NULL
like	NULL
the	NULL
known	NULL
Oct-1	NULL
,	NULL
Oct-2A	NULL
,	NULL
and	NULL
Oct-2B	NULL
proteins	NULL
(	NULL
Kemler	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
,	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
and	NULL
the	NULL
N-Oct-2	NULL
proteins	NULL
recognize	NULL
also	NULL
the	NULL
heptamer	NULL
element	NULL
CTCATGA	NULL
of	NULL
the	NULL
IgH	NULL
promoter	NULL
.	NULL

We	NULL
therefore	NULL
suspect	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
N-Oct-2	NULL
«	NULL
and	NULL
(	NULL
3	NULL
and	NULL
N-Oct-3	NULL
contain	NULL
homologies	NULL
with	NULL
the	NULL
POU-homeo	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
known	NULL
Oct-proteins	NULL
.	NULL

In	NULL
order	NULL
to	NULL
isolate	NULL
additional	NULL
members	NULL
of	NULL
the	NULL
POU-domain	NULL
containing	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
oligonucleotide	NULL
primers	NULL
that	NULL
comprised	NULL
the	NULL
conserved	NULL
nucleotide	NULL
residues	NULL
of	NULL
the	NULL
four	NULL
POU	NULL
domains	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
cDNAs	NULL
from	NULL
rat	NULL
brain	NULL
mRNA	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
He	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Three	NULL
amplification	NULL
products	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
(	NULL
brain	NULL
)	NULL
Brn-1	NULL
,	NULL
Brn-2	NULL
,	NULL
and	NULL
Brn-3	NULL
,	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
highly	NULL
homologous	NULL
,	NULL
but	NULL
not	NULL
identical	NULL
,	NULL
to	NULL
known	NULL
POU-domains	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
amplification	NULL
products	NULL
were	NULL
shown	NULL
to	NULL
differentially	NULL
hybridize	NULL
in	NULL
situ	NULL
to	NULL
certain	NULL
segments	NULL
and	NULL
regions	NULL
of	NULL
the	NULL
brain	NULL
(	NULL
He	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
at	NULL
least	NULL
some	NULL
of	NULL
these	NULL
amplified	NULL
transcripts	NULL
correspond	NULL
to	NULL
the	NULL
novel	NULL
octamer	NULL
binding	NULL
proteins	NULL
described	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Recently	NULL
,	NULL
Monuki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
and	NULL
He	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
isolated	NULL
cDNAs	NULL
encoding	NULL
a	NULL
POU-domain	NULL
containing	NULL
factor	NULL
,	NULL
termed	NULL
SCIP	NULL
(	NULL
or	NULL
tst-1	NULL
respectively	NULL
)	NULL
,	NULL
that	NULL
is	NULL
present	NULL
in	NULL
myelin-forming	NULL
glia	NULL
cells	NULL
but	NULL
absent	NULL
in	NULL
astrocytes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
this	NULL
factor	NULL
is	NULL
cAMP	NULL
inducible	NULL
and	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
as	NULL
a	NULL
primary	NULL
step	NULL
in	NULL
the	NULL
cascade	NULL
of	NULL
progressive	NULL
determination	NULL
of	NULL
myelination	NULL
.	NULL

Although	NULL
all	NULL
sequenced	NULL
genes	NULL
of	NULL
genuine	NULL
octamer	NULL
DNA-binding	NULL
proteins	NULL
contain	NULL
POU-domains	NULL
,	NULL
the	NULL
reverse	NULL
may	NULL
not	NULL
be	NULL
true	NULL
;	NULL
the	NULL
actual	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
brn	NULL
1-3	NULL
factors	NULL
and	NULL
the	NULL
SCIP	NULL
(	NULL
tst-1	NULL
)	NULL
protein	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Since	NULL
the	NULL
SCIP	NULL
factor	NULL
is	NULL
absent	NULL
in	NULL
astrocytes	NULL
,	NULL
we	NULL
think	NULL
that	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

Differential	NULL
distribution	NULL
of	NULL
N-Oct	NULL
proteins	NULL
in	NULL
glial	NULL
and	NULL
neuronal	NULL
cells	NULL
Substantial	NULL
differences	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
N-Oct	NULL
proteins	NULL
in	NULL
different	NULL
human	NULL
glioblastoma	NULL
and	NULL
neuroblastoma	NULL
cell	NULL
lines	NULL
.	NULL

Both	NULL
cell	NULL
types	NULL
displayed	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
together	NULL
with	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
or	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
alone	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
data	NULL
did	NULL
not	NULL
make	NULL
it	NULL
possible	NULL
to	NULL
distinguish	NULL
the	NULL
cell	NULL
lines	NULL
according	NULL
to	NULL
their	NULL
origin	NULL
as	NULL
glial	NULL
or	NULL
neuronal	NULL
.	NULL

Remarkably	NULL
,	NULL
LN-18	NULL
and	NULL
308	NULL
glioblastoma	NULL
cells	NULL
contained	NULL
only	NULL
the	NULL
Oct-1	NULL
protein	NULL
.	NULL

Whether	NULL
this	NULL
result	NULL
represents	NULL
a	NULL
cell	NULL
line	NULL
pecularity	NULL
remains	NULL
unclear	NULL
.	NULL

We	NULL
have	NULL
now	NULL
analyzed	NULL
20	NULL
more	NULL
neuroblastoma	NULL
and	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
human	NULL
tumors	NULL
;	NULL
all	NULL
of	NULL
these	NULL
displayed	NULL
either	NULL
N-Oct-3	NULL
alone	NULL
or	NULL
N-Oct-3	NULL
together	NULL
with	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
(	NULL
our	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

We	NULL
have	NULL
yet	NULL
to	NULL
find	NULL
a	NULL
cell	NULL
line	NULL
displaying	NULL
the	NULL
N-Oct-2	NULL
complex	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
.	NULL

Astrocytes	NULL
can	NULL
be	NULL
classified	NULL
as	NULL
epitheloid	NULL
type	NULL
1	NULL
and	NULL
stellar	NULL
type-2	NULL
.	NULL

These	NULL
two	NULL
populations	NULL
belong	NULL
to	NULL
two	NULL
different	NULL
cell	NULL
lineages	NULL
;	NULL
bipotential	NULL
glial	NULL
precursors	NULL
differentiate	NULL
into	NULL
type-2	NULL
astrocytes	NULL
and	NULL
oligodendrocytes	NULL
while	NULL
type	NULL
1	NULL
astrocytes	NULL
belong	NULL
to	NULL
a	NULL
different	NULL
lineage	NULL
(	NULL
Raff	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
culture	NULL
conditions	NULL
used	NULL
in	NULL
the	NULL
present	NULL
experiments	NULL
,	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
astrocytes	NULL
express	NULL
the	NULL
Ran-2	NULL
antigen	NULL
,	NULL
a	NULL
marker	NULL
for	NULL
type-1	NULL
astrocytes	NULL
(	NULL
Massa	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
fully	NULL
differentiated	NULL
type-1	NULL
astrocytes	NULL
in	NULL
culture	NULL
express	NULL
all	NULL
of	NULL
the	NULL
N-Oct	NULL
proteins	NULL
detectable	NULL
under	NULL
our	NULL
assay	NULL
conditions	NULL
.	NULL

The	NULL
relationship	NULL
of	NULL
N-Oct	NULL
proteins	NULL
with	NULL
Oct-2	NULL
from	NULL
B-cells	NULL
The	NULL
N-Oct-2	NULL
complex	NULL
,	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
BJA-B	NULL
cells	NULL
were	NULL
compared	NULL
by	NULL
proteolytic	NULL
clipping	NULL
bandshift	NULL
analysis	NULL
in	NULL
order	NULL
to	NULL
assess	NULL
structural	NULL
similarities	NULL
and	NULL
differences	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
N-Oct-2	NULL
,	NULL
advanced	NULL
proteolytic	NULL
cleavage	NULL
results	NULL
in	NULL
the	NULL
production	NULL
of	NULL
polypeptides	NULL
which	NULL
comigrate	NULL
with	NULL
polypeptides	NULL
produced	NULL
by	NULL
similar	NULL
cleavage	NULL
of	NULL
Oct-2A	NULL
.	NULL

This	NULL
might	NULL
indicate	NULL
a	NULL
conserved	NULL
homology	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
region	NULL
between	NULL
these	NULL
proteins	NULL
.	NULL

A	NULL
similar	NULL
phenomenon	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
clipping	NULL
patterns	NULL
of	NULL
Oct-2A	NULL
,	NULL
-2B	NULL
and	NULL
Oct-l	NULL
were	NULL
compared	NULL
(	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
,	NULL
namely	NULL
the	NULL
use	NULL
of	NULL
high	NULL
protease	NULL
concentrations	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
similarly	NULL
migrating	NULL
polypeptides	NULL
.	NULL

These	NULL
results	NULL
were	NULL
interpreted	NULL
to	NULL
reflect	NULL
the	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
in	NULL
these	NULL
proteins	NULL
.	NULL

This	NULL
prediction	NULL
was	NULL
subsequently	NULL
confirmed	NULL
by	NULL
the	NULL
cloning	NULL
of	NULL
the	NULL
cDNAs	NULL
encoding	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
(	NULL
Herr	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

The	NULL
clipping	NULL
patterns	NULL
of	NULL
N-Oct-2	NULL
«	NULL
and	NULL
(	NULL
3	NULL
using	NULL
trypsin	NULL
digestion	NULL
were	NULL
found	NULL
to	NULL
be	NULL
different	NULL
,	NULL
suggesting	NULL
that	NULL
N-Oct-2	NULL
«	NULL
and	NULL
N-Oct-28	NULL
are	NULL
distinct	NULL
proteins	NULL
.	NULL

These	NULL
data	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
immunological	NULL
data	NULL
lead	NULL
us	NULL
to	NULL
conclude	NULL
that	NULL
the	NULL
N-Oct-2	NULL
a	NULL
and	NULL
{	NULL
proteins	NULL
are	NULL
not	NULL
identical	NULL
to	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
B-cells	NULL
.	NULL

When	NULL
the	NULL
protease	NULL
ArgC	NULL
was	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
relationship	NULL
between	NULL
Oct-2A	NULL
and	NULL
N-Oct	NULL
3	NULL
,	NULL
we	NULL
saw	NULL
a	NULL
similar	NULL
change	NULL
in	NULL
molecular	NULL
weight	NULL
upon	NULL
proteolytic	NULL
cleavage	NULL
which	NULL
could	NULL
reflect	NULL
a	NULL
structural	NULL
relationship	NULL
in	NULL
certain	NULL
domains	NULL
between	NULL
Oct-2A	NULL
and	NULL
N-Oct-3	NULL
.	NULL

However	NULL
,	NULL
the	NULL
N-Oct-3	NULL
protein	NULL
,	NULL
the	NULL
N-Oct-2	NULL
«	NULL
/B	NULL
complex	NULL
,	NULL
and	NULL
all	NULL
other	NULL
N-Oct	NULL
factors	NULL
were	NULL
not	NULL
at	NULL
all	NULL
recognized	NULL
by	NULL
specific	NULL
antisera	NULL
directed	NULL
against	NULL
recombinant	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
protein	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
consider	NULL
it	NULL
most	NULL
likely	NULL
that	NULL
the	NULL
N-Oct	NULL
factor	NULL
genes	NULL
are	NULL
different	NULL
from	NULL
the	NULL
oct-1	NULL
or	NULL
oct-2	NULL
genes	NULL
.	NULL

This	NULL
finding	NULL
contrasts	NULL
with	NULL
a	NULL
report	NULL
indicating	NULL
Oct-2	NULL
to	NULL
be	NULL
present	NULL
also	NULL
in	NULL
nervous	NULL
system	NULL
cells	NULL
(	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
Staudt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
showed	NULL
that	NULL
a	NULL
human	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
expressed	NULL
the	NULL
Oct-2	NULL
mRNA	NULL
when	NULL
tested	NULL
by	NULL
Northern	NULL
blot	NULL
using	NULL
an	NULL
Oct-2	NULL
cDNA	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
an	NULL
RNA	NULL
probe	NULL
containing	NULL
the	NULL
entire	NULL
POU-domain	NULL
revealed	NULL
expression	NULL
of	NULL
Oct-2	NULL
mRNA	NULL
in	NULL
rat	NULL
brain	NULL
tissue	NULL
(	NULL
He	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
have	NULL
clearly	NULL
shown	NULL
that	NULL
the	NULL
Oct-2A	NULL
protein	NULL
from	NULL
B-cells	NULL
is	NULL
absent	NULL
from	NULL
astrocytes	NULL
and	NULL
from	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
tumors	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
the	NULL
RNA	NULL
hybridization	NULL
results	NULL
which	NULL
imply	NULL
oct-2	NULL
expression	NULL
in	NULL
the	NULL
brain	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
extensive	NULL
sequence	NULL
homologies	NULL
between	NULL
the	NULL
Oct-2	NULL
gene	NULL
and	NULL
N-Oct-factor	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Sequence	NULL
homologies	NULL
are	NULL
most	NULL
likely	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
POU-homeo	NULL
DNA-binding	NULL
region	NULL
.	NULL

Alternatively	NULL
,	NULL
if	NULL
the	NULL
oct-2	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
brain	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
detectable	NULL
quantities	NULL
of	NULL
Oct-2	NULL
protein	NULL
,	NULL
one	NULL
must	NULL
consider	NULL
a	NULL
mechanism	NULL
that	NULL
blocks	NULL
translation	NULL
of	NULL
oct-2	NULL
transcripts	NULL
or	NULL
prevents	NULL
DNA-binding	NULL
of	NULL
the	NULL
protein	NULL
e.g	NULL
.	NULL

by	NULL
an	NULL
inhibiting	NULL
factor	NULL
.	NULL

A	NULL
lymphoid-specific	NULL
promoter	NULL
is	NULL
neither	NULL
stimulated	NULL
nor	NULL
repressed	NULL
in	NULL
N-Oct-3	NULL
containing	NULL
cells	NULL
The	NULL
octamer	NULL
motif	NULL
present	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
promoters	NULL
and	NULL
in	NULL
the	NULL
heavy	NULL
chain	NULL
enhancer	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
as	NULL
a	NULL
determinant	NULL
of	NULL
B	NULL
cell	NULL
specificity	NULL
(	NULL
reviewed	NULL
in	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
octamer	NULL
motif	NULL
is	NULL
not	NULL
only	NULL
restricted	NULL
to	NULL
immunoglobulin	NULL
promoters	NULL
;	NULL
in	NULL
addition	NULL
to	NULL
some	NULL
housekeeping	NULL
genes	NULL
,	NULL
it	NULL
is	NULL
also	NULL
present	NULL
in	NULL
promoters	NULL
of	NULL
specifically	NULL
expressed	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
ones	NULL
coding	NULL
for	NULL
MHC	NULL
class	NULL
II	NULL
protein	NULL
(	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
,	NULL
the	NULL
interleukin	NULL
1	NULL
,	NULL
and	NULL
the	NULL
granulocyte	NULL
colony	NULL
stimulating	NULL
factor	NULL
(	NULL
J.	NULL
Blaszczynski	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
inducible	NULL
in	NULL
astrocytes	NULL
(	NULL
Fontana	NULL
et	NULL
al	NULL
.	NULL

1982	NULL
and	NULL
1984	NULL
;	NULL
Malipiero	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
and	NULL
thus	NULL
N-Oct	NULL
factors	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
their	NULL
regulation	NULL
.	NULL

It	NULL
is	NULL
also	NULL
conceivable	NULL
that	NULL
target	NULL
promoters/enhancers	NULL
of	NULL
N-Oct	NULL
factors	NULL
contain	NULL
the	NULL
heptamer	NULL
site	NULL
CTCATGA	NULL
,	NULL
since	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
N-Oct	NULL
proteins	NULL
can	NULL
specifically	NULL
bind	NULL
to	NULL
this	NULL
sequence	NULL
.	NULL

Another	NULL
candidate	NULL
for	NULL
activation	NULL
by	NULL
N-Oct	NULL
factors	NULL
is	NULL
the	NULL
human	NULL
calcitonin/	NULL
«	NULL
-CGRP	NULL
gene	NULL
.	NULL

This	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
neural	NULL
and	NULL
thyroid	NULL
tissues	NULL
and	NULL
contains	NULL
an	NULL
octamer	NULL
site	NULL
at	NULL
position	NULL
-160	NULL
(	NULL
Broad	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
conceivable	NULL
that	NULL
N-Oct	NULL
factors	NULL
serve	NULL
to	NULL
downregulate	NULL
certain	NULL
genes	NULL
.	NULL

This	NULL
hypothesis	NULL
gained	NULL
support	NULL
by	NULL
a	NULL
recent	NULL
report	NULL
of	NULL
Kemp	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
authors	NULL
could	NULL
show	NULL
that	NULL
the	NULL
octamer	NULL
motif	NULL
mediates	NULL
transcriptional	NULL
repression	NULL
of	NULL
Herpes	NULL
simplex	NULL
virus	NULL
immediate	NULL
early	NULL
genes	NULL
in	NULL
C1300	NULL
neuroblastoma	NULL
cells	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
specificity	NULL
of	NULL
N-Oct-3	NULL
factor	NULL
,	NULL
we	NULL
have	NULL
assayed	NULL
for	NULL
activation	NULL
and	NULL
repression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
that	NULL
contains	NULL
an	NULL
octamer-TATA	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
readily	NULL
activated	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
ectopic	NULL
overexpression	NULL
of	NULL
Oct-2A	NULL
protein	NULL
but	NULL
not	NULL
by	NULL
the	NULL
endogenous	NULL
Oct-1	NULL
protein	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

1988b	NULL
)	NULL
.	NULL

This	NULL
promoter	NULL
construct	NULL
was	NULL
not	NULL
activated	NULL
after	NULL
transfection	NULL
into	NULL
Bowes	NULL
melanoma	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
both	NULL
Oct-1	NULL
and	NULL
N-Oct-3	NULL
protein	NULL
.	NULL

A	NULL
trivial	NULL
explanation	NULL
for	NULL
this	NULL
observation	NULL
could	NULL
be	NULL
a	NULL
low	NULL
N-Oct-3	NULL
factor	NULL
concentration	NULL
;	NULL
ectopic	NULL
overexpression	NULL
of	NULL
the	NULL
N-Oct-3	NULL
cDNA	NULL
,	NULL
which	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
cloned	NULL
,	NULL
may	NULL
clarify	NULL
this	NULL
issue	NULL
.	NULL

Co-transfection	NULL
of	NULL
the	NULL
Oct-2A	NULL
cDNA	NULL
,	NULL
however	NULL
,	NULL
gave	NULL
strong	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
in	NULL
Bowes	NULL
cells	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
earlier	NULL
findings	NULL
with	NULL
HeLa	NULL
cells	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988b	NULL
)	NULL
.	NULL

At	NULL
least	NULL
under	NULL
our	NULL
assay	NULL
conditions	NULL
,	NULL
N-Oct-3	NULL
protein	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
lymphoid	NULL
specific	NULL
promoter	NULL
upon	NULL
co-expression	NULL
with	NULL
Oct-2A	NULL
protein	NULL
.	NULL

We	NULL
consider	NULL
it	NULL
likely	NULL
that	NULL
N-Oct-3	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
for	NULL
genes	NULL
specifically	NULL
expressed	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
nervous	NULL
system	NULL
and	NULL
related	NULL
cell	NULL
types	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Fritz	NULL
Ochsenbein	NULL
for	NULL
his	NULL
expert	NULL
graphical	NULL
work	NULL
and	NULL
Dr.	NULL
Michael	NULL
M.	NULL
Miiller-Immergliick	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

We	NULL
are	NULL
obliged	NULL
to	NULL
Dr.	NULL
Sandro	NULL
Rusconi	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
Jacek	NULL
Blaszezynski	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
of	NULL
the	NULL
Swiss	NULL
National	NULL
Science	NULL
Foundation	NULL
,	NULL
by	NULL
the	NULL
Kanton	NULL
of	NULL
Zirich	NULL
,	NULL
and	NULL
by	NULL
the	NULL
Swiss	NULL
National	NULL
Multiple	NULL
Sclerosis	NULL
Society	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Banerji	NULL
,	NULL
J.	NULL
,	NULL
Rusconi	NULL
,	NULL
S.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1981	NULL
)	NULL
Cell	NULL
,	NULL
27	NULL
,	NULL
299-308	NULL
2	NULL
.	NULL

Barberis	NULL
,	NULL
A.	NULL
,	NULL
Superti-Furga	NULL
,	NULL
G.	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
50	NULL
,	NULL
347-359	NULL
3	NULL
.	NULL

Biedler	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Roffler-Tarlov	NULL
,	NULL
S.	NULL
,	NULL
Schachner	NULL
,	NULL
M.	NULL
and	NULL
Freedman	NULL
,	NULL
L.S	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
38	NULL
,	NULL
3761-3757	NULL
4	NULL
.	NULL

Bissell	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Rubinstein	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Bignami	NULL
,	NULL
A.	NULL
and	NULL
Hermann	NULL
,	NULL
M.M	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Brain	NULL
Res	NULL
.	NULL

28	NULL
,	NULL
77-82	NULL
5	NULL
.	NULL

Broad	NULL
,	NULL
P.M.	NULL
,	NULL
Symes	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Thakker	NULL
,	NULL
R.V	NULL
.	NULL

and	NULL
Craig	NULL
,	NULL
R.K.	NULL
(	NULL
1989	NULL
)	NULL
Nucl	NULL
.	NULL

Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6999-7011	NULL
6	NULL
.	NULL

Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Corcoran	NULL
,	NULL
L.M	NULL
.	NULL

,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Baltimore	NULL
,	NULL
D.	NULL
and	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
and	NULL
Development	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1570-1581	NULL
7	NULL
.	NULL

Cox	NULL
,	NULL
P.M.	NULL
,	NULL
Temperley	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Kumar	NULL
,	NULL
H.	NULL
and	NULL
Goding	NULL
,	NULL
C.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
16	NULL
,	NULL
11047-11056	NULL
8	NULL
.	NULL

Dreyfus	NULL
,	NULL
M.	NULL
,	NULL
Doyen	NULL
,	NULL
N.	NULL
and	NULL
Rougeon	NULL
,	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
6	NULL
,	NULL
1685-1690	NULL
9	NULL
.	NULL

Falkner	NULL
,	NULL
F.G.	NULL
and	NULL
Zachau	NULL
,	NULL
H.G	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
,	NULL
310	NULL
,	NULL
71-74	NULL
10	NULL
.	NULL

Fletcher	NULL
,	NULL
C.	NULL
,	NULL
Heintz	NULL
,	NULL
N.	NULL
and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
51	NULL
,	NULL
773-781	NULL
11	NULL
.	NULL

Fontana	NULL
,	NULL
A.	NULL
,	NULL
Fierz	NULL
,	NULL
W.	NULL
and	NULL
Wekerle	NULL
,	NULL
H.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
,	NULL
307	NULL
,	NULL
273-276	NULL
12	NULL
.	NULL

Fontana	NULL
,	NULL
A.	NULL
,	NULL
Kristensen	NULL
,	NULL
F.	NULL
,	NULL
Dubs	NULL
,	NULL
R.	NULL
,	NULL
Gemsa	NULL
,	NULL
D.	NULL
and	NULL
Weber	NULL
,	NULL
E.	NULL
(	NULL
1982	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
129	NULL
,	NULL
2413-2419	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
.	NULL

Miwa	NULL
,	NULL
K.	NULL
and	NULL
Strominger	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
15	NULL
,	NULL
8057-8067	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

52	NULL
.	NULL

Sturm	NULL
,	NULL
R.A.	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
336	NULL
,	NULL
601-604	NULL
53	NULL
.	NULL

55	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

18	NULL
5503	NULL
Frei	NULL
,	NULL
K.	NULL
,	NULL
Siepl	NULL
,	NULL
C.	NULL
,	NULL
Groscurth	NULL
,	NULL
P.	NULL
,	NULL
Bodmer	NULL
,	NULL
S.	NULL
,	NULL
Schwerdel	NULL
,	NULL
C.	NULL
and	NULL
Fontana	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
1272-1278	NULL
Garcia-Blanco	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Clerc	NULL
,	NULL
R.	NULL
and	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
and	NULL
Development	NULL
.	NULL

,	NULL
3	NULL
,	NULL
739-745	NULL
Gough	NULL
,	NULL
N.M.	NULL
(	NULL
1988	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
173	NULL
,	NULL
93-95	NULL
Harvey	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
Robins	NULL
,	NULL
A.J	NULL
.	NULL

and	NULL
Wells	NULL
,	NULL
J.R.E	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
10	NULL
,	NULL
7851-7863	NULL
He	NULL
,	NULL
X.	NULL
,	NULL
Treacy	NULL
,	NULL
M.N	NULL
.	NULL

,	NULL
Simmons	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Swanson	NULL
,	NULL
L.	NULL
W.	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
340	NULL
,	NULL
35-42	NULL
Herr	NULL
,	NULL
W.	NULL
,	NULL
Sturm	NULL
,	NULL
R.A.	NULL
,	NULL
Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Ingraham	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Finney	NULL
,	NULL
M.	NULL
,	NULL
Ruvkun	NULL
,	NULL
G.	NULL
and	NULL
Horvitz	NULL
,	NULL
H.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
and	NULL
Development	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1513-1516	NULL
Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
R.	NULL
,	NULL
Mangalam	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Elsholtz	NULL
,	NULL
H.P	NULL
.	NULL

,	NULL
Flynn	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Lin	NULL
,	NULL
C.R	NULL
.	NULL

,	NULL
Simmons	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Swanson	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
519-529	NULL
.	NULL

Johnsn	NULL
,	NULL
P.F	NULL
.	NULL

and	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
58	NULL
,	NULL
799-839	NULL
Kemler	NULL
,	NULL
I.	NULL
,	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Matthias	NULL
,	NULL
P.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
2001-2008	NULL
Kemp	NULL
,	NULL
L	NULL
.	NULL

M.	NULL
,	NULL
Dent	NULL
,	NULL
C.L	NULL
.	NULL

und	NULL
Latchman	NULL
,	NULL
D.	NULL
$	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Neuron	NULL
,	NULL
4	NULL
,	NULL
215-222	NULL
.	NULL

Krimpenfort	NULL
,	NULL
P.	NULL
,	NULL
de	NULL
Jong	NULL
,	NULL
R.	NULL
,	NULL
Uematsu	NULL
,	NULL
Y.	NULL
,	NULL
Dembic	NULL
,	NULL
Z.	NULL
,	NULL
Ryser	NULL
,	NULL
S.	NULL
,	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
,	NULL
Steinmetz	NULL
,	NULL
M.	NULL
and	NULL
Berns	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
7	NULL
,	NULL
745-750	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
,	NULL
Robbins	NULL
,	NULL
P.	NULL
,	NULL
Kuang	NULL
,	NULL
A.	NULL
,	NULL
Mulligan	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
,	NULL
243	NULL
,	NULL
544-546	NULL
.	NULL

Malipiero	NULL
,	NULL
U.	NULL
,	NULL
Frei	NULL
,	NULL
K.	NULL
and	NULL
Fontana	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
Fischer	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Science	NULL
,	NULL
236	NULL
,	NULL
1237-1245	NULL
.	NULL

Marzouki	NULL
,	NULL
N.	NULL
,	NULL
Camier	NULL
,	NULL
D.	NULL
,	NULL
Ruet	NULL
,	NULL
A.	NULL
,	NULL
Moenne	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Sentenac	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
323	NULL
,	NULL
177-178	NULL
Massa	NULL
,	NULL
P.T	NULL
.	NULL

,	NULL
ter	NULL
Meulen	NULL
,	NULL
V.	NULL
and	NULL
Fontana	NULL
,	NULL
A	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
4219-4223	NULL
.	NULL

Mitchell	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
,	NULL
245	NULL
,	NULL
371-378	NULL
Moniki	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Weinmaster	NULL
,	NULL
G.	NULL
,	NULL
Kuhn	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Lemke	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Neuron	NULL
,	NULL
3	NULL
,	NULL
783-793	NULL
.	NULL

Miller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Gerster	NULL
,	NULL
T.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1988a	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
176	NULL
,	NULL
485-495	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
w.	NULL
and	NULL
Matthias	NULL
P.	NULL
(	NULL
1988b	NULL
)	NULL
Nature	NULL
,	NULL
336	NULL
,	NULL
544-551	NULL
.	NULL

Miller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1989¢	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6420	NULL
.	NULL

Parslow	NULL
,	NULL
T.G	NULL
.	NULL

,	NULL
Blair	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Murphy	NULL
,	NULL
W.J	NULL
.	NULL

and	NULL
Granner	NULL
,	NULL
D.K	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
81	NULL
,	NULL
2650-2654	NULL
.	NULL

Poellinger	NULL
,	NULL
L.	NULL
and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
747-756	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
335	NULL
,	NULL
683-689	NULL
.	NULL

Raff	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Miller	NULL
,	NULL
R.H	NULL
.	NULL

and	NULL
Noble	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Nature	NULL
,	NULL
303	NULL
,	NULL
390-396.	NULL
.	NULL

Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Trends	NULL
in	NULL
Genetics	NULL
,	NULL
5	NULL
,	NULL
37-39	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Cromlish	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.-G.	NULL
,	NULL
Currie	NULL
,	NULL
A.	NULL
and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
336	NULL
,	NULL
551-557	NULL
Schnegg	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Diserens	NULL
,	NULL
A.C.	NULL
,	NULL
Carrel	NULL
,	NULL
S.	NULL
,	NULL
Accolla	NULL
,	NULL
R.S	NULL
.	NULL

and	NULL
de	NULL
Tribolet	NULL
,	NULL
N.	NULL
(	NULL
1981	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
41	NULL
,	NULL
12090-1213	NULL
Scholer	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Hatzopoulos	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
Balling	NULL
,	NULL
R.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
2543-2550	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
7	NULL
,	NULL
4221-4229	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6419	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
W.	NULL
and	NULL
Matthias	NULL
,	NULL
P	NULL
:	NULL
(	NULL
1989	NULL
)	NULL
In	NULL
Tissue	NULL
specific	NULL
gene	NULL
expression	NULL
(	NULL
ed	NULL
.	NULL

R.	NULL
Renkawitz	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

33-54	NULL
.	NULL

VCH-Verlagsgesellschaft	NULL
,	NULL
Weinheim	NULL
Germany	NULL
.	NULL

Seeger	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
Rayner	NULL
,	NULL
S.A.	NULL
,	NULL
Banerjee	NULL
,	NULL
A.	NULL
,	NULL
Chung	NULL
,	NULL
H.	NULL
,	NULL
Laug	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Neustein	NULL
,	NULL
R.	NULL
and	NULL
Benedict	NULL
,	NULL
W.F	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
37	NULL
,	NULL
1364-1371	NULL
Sherman	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Basta	NULL
,	NULL
P.V	NULL
.	NULL

,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Wloch	NULL
,	NULL
MK	NULL
.	NULL

,	NULL
Roeder	NULL
,	NULL
R.	NULL
and	NULL
Ting	NULL
,	NULL
J.P.-Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
USA	NULL
,	NULL
86	NULL
,	NULL
6739-6743	NULL
Siebenlist	NULL
,	NULL
U.	NULL
and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
77	NULL
,	NULL
122-126	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
241	NULL
,	NULL
577-580	NULL
Studier	NULL
,	NULL
F.W	NULL
.	NULL

,	NULL
and	NULL
Moffat	NULL
,	NULL
B.A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

189	NULL
,	NULL
113-130	NULL
.	NULL

Sturm	NULL
,	NULL
R.A.	NULL
,	NULL
Das	NULL
,	NULL
G.	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
and	NULL
Development	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1582-1599	NULL
Thali	NULL
,	NULL
M.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
DeLorenzi	NULL
,	NULL
M.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
and	NULL
Bienz	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
336	NULL
,	NULL
598-601	NULL
.	NULL

Westin	NULL
,	NULL
G.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
G.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
15	NULL
,	NULL
6787-6798	NULL
Wirth	NULL
,	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
329	NULL
,	NULL
174-178	NULL

